<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>POMT1 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>POMT1</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9Y6A1" target="_blank" class="term-link">
                        Q9Y6A1
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-draft">
                    DRAFT
                </span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Aliases:</span>
                <div class="aliases">
                    
                    <span class="badge">Protein O-mannosyl-transferase 1</span>
                    
                    <span class="badge">Dolichyl-phosphate-mannose--protein mannosyltransferase 1</span>
                    
                </div>
            </div>
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "POMT1";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9Y6A1" data-a="DESCRIPTION: Protein O-mannosyltransferase 1, glycosyltransfera..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>Protein O-mannosyltransferase 1, glycosyltransferase (EC 2.4.1.109) that catalyzes the first committed step in protein O-mannose glycan biosynthesis by transferring mannose from dolichol-phosphate-mannose to serine/threonine hydroxyl groups on target proteins. Forms obligate heteromeric complex with POMT2 in 1:1 stoichiometry - individually neither subunit has enzymatic activity, only the POMT1/POMT2 complex is functional. ER-resident integral membrane protein with ~10 transmembrane helices and luminal catalytic domains facing ER lumen. Belongs to GT-C superfamily of glycosyltransferases with conserved acidic residues in first luminal loop forming active site that binds dolichol-P-mannose. Contains MIR domains and TPR repeats predicted to mediate protein substrate recognition; no short consensus sequence motif identified - substrate recognition depends on folded protein context and structural features rather than linear sequence. Primary physiological substrate: Œ±-dystroglycan (Œ±-DG), an ECM receptor glycoprotein requiring O-mannose glycan (matriglycan) to bind laminin, agrin, and perlecan. POMT1/2 initiate attachment of mannose on specific Thr residues (e.g. Thr-317, Thr-379) which primes sites for elongation into core M1/M2/M3 glycan structures - subsequent enzymes add GalNAc, xylose, ribitol-phosphate, and ultimately LARGE1 polymerizes matriglycan repeating disaccharide that directly binds ECM ligands. Without initial mannose from POMT1, entire carbohydrate scaffold cannot be built. Loss of POMT1 causes hypoglycosylation of Œ±-dystroglycan, disrupting muscle-ECM anchorage. Other substrates: receptor protein tyrosine phosphatases (RPTPŒ∂/phosphacan) carrying O-mannose glycans with HNK-1 epitopes in neural development, KIAA1549, PTP69D in fly for sensory axon guidance. POMT1-mediated O-mannosylation extends to cell-surface receptors in neural circuit formation. Critical for basement membrane assembly: Pomt1 knockout mice are embryonically lethal due to failure of Reichert&#39;s membrane formation (non-functional dystroglycan). Dystrophin-glycoprotein complex: Œ±-dystroglycan (heavily O-mannosylated) binds extracellular laminin while Œ≤-dystroglycan links to cytoskeleton via dystrophin, stabilizing muscle fibers during contraction. Mutations cause Walker-Warburg syndrome (WWS, ~20% of cases), severe congenital muscular dystrophy with brain malformations (cobblestone lissencephaly, hydrocephalus), eye defects (retinal dysplasia), early lethality; also limb-girdle muscular dystrophy 2K (LGMD2K) with later-onset milder muscle weakness but often intellectual disability. POMT1 mutations tend to have CNS involvement even in milder forms. One of three mammalian protein O-mannosyltransferase families (others: TMTC1-4 for cadherins, TMEM260 for plexin/RON/MET) - POMT1/2 uniquely responsible for dystroglycan-type pathways, occupying non-redundant niche. Acts early in secretory pathway modifying nascent polypeptides in ER lumen before Golgi trafficking. Essential for muscle fiber integrity, brain cortical layering, eye development, peripheral nerve myelination. Substrate specificity is broad in function but narrow in occurrence - targets select set of large extracellular/membrane proteins requiring O-mannose for function.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005783" target="_blank" class="term-link">
                                    GO:0005783
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0005783" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Endoplasmic reticulum from phylogeny.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004169" target="_blank" class="term-link">
                                    GO:0004169
                                </a>
                            </span>
                            <span class="term-label">dolichyl-phosphate-mannose-protein mannosyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0004169" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> O-mannosyltransferase activity - core enzymatic function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core catalytic activity.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035269" target="_blank" class="term-link">
                                    GO:0035269
                                </a>
                            </span>
                            <span class="term-label">protein O-linked glycosylation via mannose</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0035269" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Protein O-linked glycosylation via mannose - most specific term.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000030" target="_blank" class="term-link">
                                    GO:0000030
                                </a>
                            </span>
                            <span class="term-label">mannosyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0000030" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Mannosyltransferase activity from InterPro.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004169" target="_blank" class="term-link">
                                    GO:0004169
                                </a>
                            </span>
                            <span class="term-label">dolichyl-phosphate-mannose-protein mannosyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0004169" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> O-mannosyltransferase activity from family assignment. Core enzymatic function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core catalytic activity - POMT1 transfers mannose from dolichol-P-mannose to proteins.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0005789" data-r="GO_REF:0000044" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ER membrane from subcellular location.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Duplicate.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006493" target="_blank" class="term-link">
                                    GO:0006493
                                </a>
                            </span>
                            <span class="term-label">protein O-linked glycosylation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0006493" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Protein O-linked glycosylation from keywords.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Duplicate of IBA annotation.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016020" target="_blank" class="term-link">
                                    GO:0016020
                                </a>
                            </span>
                            <span class="term-label">membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0016020" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Membrane from keywords.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> General membrane localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016740" target="_blank" class="term-link">
                                    GO:0016740
                                </a>
                            </span>
                            <span class="term-label">transferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0016740" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Transferase activity from keywords.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> General enzyme class.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016757" target="_blank" class="term-link">
                                    GO:0016757
                                </a>
                            </span>
                            <span class="term-label">glycosyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0016757" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Glycosyltransferase activity from InterPro domain. GT-C superfamily.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Broad classification of core function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046872" target="_blank" class="term-link">
                                    GO:0046872
                                </a>
                            </span>
                            <span class="term-label">metal ion binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0046872" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Metal ion binding from keywords. May require divalent cations.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Many glycosyltransferases use metal cofactors.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0001669" target="_blank" class="term-link">
                                    GO:0001669
                                </a>
                            </span>
                            <span class="term-label">acrosomal vesicle</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0001669" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Acrosome assembly from Ensembl orthology.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Context-specific, not core.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016529" target="_blank" class="term-link">
                                    GO:0016529
                                </a>
                            </span>
                            <span class="term-label">sarcoplasmic reticulum</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0016529" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Sarcoplasmic reticulum from Ensembl. POMT1 in ER not SR.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Incorrect organelle.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030198" target="_blank" class="term-link">
                                    GO:0030198
                                </a>
                            </span>
                            <span class="term-label">extracellular matrix organization</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0030198" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Extracellular matrix organization via dystroglycan.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Downstream consequence.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031502" target="_blank" class="term-link">
                                    GO:0031502
                                </a>
                            </span>
                            <span class="term-label">dolichyl-phosphate-mannose-protein mannosyltransferase complex</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0031502" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Dolichyl-diphosphooligosaccharide-protein glycosyltransferase complex.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Related but not exact complex type.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004169" target="_blank" class="term-link">
                                    GO:0004169
                                </a>
                            </span>
                            <span class="term-label">dolichyl-phosphate-mannose-protein mannosyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-9816277
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0004169" data-r="Reactome:R-HSA-9816277" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> O-mannosyltransferase activity - core enzymatic function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core catalytic activity.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031502" target="_blank" class="term-link">
                                    GO:0031502
                                </a>
                            </span>
                            <span class="term-label">dolichyl-phosphate-mannose-protein mannosyltransferase complex</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/16698797" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:16698797
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Physical and functional association of human protein O-manno...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0031502" data-r="PMID:16698797" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Dolichyl-diphosphooligosaccharide-protein glycosyltransferase complex.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Related but not exact complex type.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035269" target="_blank" class="term-link">
                                    GO:0035269
                                </a>
                            </span>
                            <span class="term-label">protein O-linked glycosylation via mannose</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/16698797" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:16698797
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Physical and functional association of human protein O-manno...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0035269" data-r="PMID:16698797" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Protein O-linked glycosylation via mannose - most specific term.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000030" target="_blank" class="term-link">
                                    GO:0000030
                                </a>
                            </span>
                            <span class="term-label">mannosyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/28512129" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:28512129
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Mammalian O-mannosylation of cadherins and plexins is indepe...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0000030" data-r="PMID:28512129" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Mannosyltransferase activity from InterPro.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035269" target="_blank" class="term-link">
                                    GO:0035269
                                </a>
                            </span>
                            <span class="term-label">protein O-linked glycosylation via mannose</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/28512129" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:28512129
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Mammalian O-mannosylation of cadherins and plexins is indepe...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0035269" data-r="PMID:28512129" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Protein O-linked glycosylation via mannose - most specific term.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5615556
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0005789" data-r="Reactome:R-HSA-5615556" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ER membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5615604
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0005789" data-r="Reactome:R-HSA-5615604" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ER membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-5615637
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0005789" data-r="Reactome:R-HSA-5615637" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ER membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000030" target="_blank" class="term-link">
                                    GO:0000030
                                </a>
                            </span>
                            <span class="term-label">mannosyltransferase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10366449" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10366449
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of a human homolog of the Drosophila rotated ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0000030" data-r="PMID:10366449" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Mannosyltransferase activity from InterPro.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core function.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005783" target="_blank" class="term-link">
                                    GO:0005783
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10366449" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10366449
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of a human homolog of the Drosophila rotated ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0005783" data-r="PMID:10366449" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Endoplasmic reticulum.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006493" target="_blank" class="term-link">
                                    GO:0006493
                                </a>
                            </span>
                            <span class="term-label">protein O-linked glycosylation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10366449" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10366449
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of a human homolog of the Drosophila rotated ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0006493" data-r="PMID:10366449" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Protein O-linked glycosylation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core process.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016020" target="_blank" class="term-link">
                                    GO:0016020
                                </a>
                            </span>
                            <span class="term-label">membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10366449" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10366449
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of a human homolog of the Drosophila rotated ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0016020" data-r="PMID:10366449" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> General localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                    GO:0005789
                                </a>
                            </span>
                            <span class="term-label">endoplasmic reticulum membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/14699049" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:14699049
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Demonstration of mammalian protein O-mannosyltransferase act...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y6A1" data-a="GO:0005789" data-r="PMID:14699049" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ER membrane.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Core localization.
                        </div>
                        
                        
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Catalyzing transfer of mannose from dolichol-phosphate-mannose donor to serine/threonine residues on protein substrates in ER lumen, as obligate heteromeric complex with POMT2. First committed step in O-mannose glycan biosynthesis - without this mannose, downstream glycan assembly cannot occur. Primary substrate Œ±-dystroglycan requires this modification for ECM binding.</h3>
                <span class="vote-buttons" data-g="Q9Y6A1" data-a="FUNCTION: Catalyzing transfer of mannose from dolichol-phosp..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004169" target="_blank" class="term-link">
                            dolichyl-phosphate-mannose-protein mannosyltransferase activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035269" target="_blank" class="term-link">
                                protein O-linked glycosylation via mannose
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007155" target="_blank" class="term-link">
                                cell adhesion
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005789" target="_blank" class="term-link">
                                endoplasmic reticulum membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/POMT1/POMT1-uniprot.txt
                            
                        </span>
                        
                        <div class="finding-text">POMT1 with POMT2 initiates O-mannose glycan on Œ±-dystroglycan. Mutations cause Walker-Warburg syndrome due to failed dystroglycan glycosylation and loss of ECM binding.</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10366449" target="_blank" class="term-link">
                            PMID:10366449
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification of a human homolog of the Drosophila rotated abdomen gene (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment to human chromosome 9q34.1.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/14699049" target="_blank" class="term-link">
                            PMID:14699049
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16698797" target="_blank" class="term-link">
                            PMID:16698797
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Physical and functional association of human protein O-mannosyltransferases 1 and 2.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28512129" target="_blank" class="term-link">
                            PMID:28512129
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Mammalian O-mannosylation of cadherins and plexins is independent of protein O-mannosyltransferases 1 and 2.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5615556
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective POMT2 does not transfer Man from Dol-P-Man to DAG1</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5615604
                        
                    </span>
                </div>
                
                <div class="reference-title">Defective POMT1 does not transfer Man from Dol-P-Man to DAG1</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-5615637
                        
                    </span>
                </div>
                
                <div class="reference-title">POMT1:POMT2 transfers Man from Dol-P-Man to DAG1(30-653)</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-9816277
                        
                    </span>
                </div>
                
                <div class="reference-title">CDH1 is O-manosylated</div>
                
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Openai</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(POMT1-deep-research-openai.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y6A1" data-a="DOC: Deep Research Openai" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: openai<br />
model: o3-deep-research-2025-06-26<br />
cached: true<br />
start_time: '2025-11-03T21:42:18.871818'<br />
end_time: '2025-11-03T21:42:18.873405'<br />
duration_seconds: 0.0<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: Q9Y6A1<br />
  gene_symbol: POMT1<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    temperature: 0.1<br />
    top_p: 1.0<br />
citation_count: 127</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene POMT1 (Q9Y6A1) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="pomt1-protein-o-mannosyltransferase-1-function-processes-and-localization">POMT1 (Protein O-Mannosyltransferase 1) ‚Äì Function, Processes, and Localization</h1>
<h2 id="overview-and-key-function-of-pomt1">Overview and Key Function of POMT1</h2>
<p><strong>POMT1</strong> (UniProt Q9Y6A1) encodes <strong>protein O-mannosyltransferase 1</strong>, an enzyme that catalyzes the addition of mannose sugars to proteins as part of a unique glycosylation pathway. POMT1 is a <strong>glycosyltransferase</strong> that performs <strong>O-linked mannosylation</strong> ‚Äì it transfers mannose from a lipid-linked donor (dolichol phosphate mannose) to the hydroxyl group of serine or threonine residues on target proteins (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>). This reaction represents the first committed step in the <strong>protein O-mannose glycan biosynthesis</strong> pathway, which is crucial for the proper function of several extracellular and cell-surface glycoproteins (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>). POMT1‚Äôs activity is <strong>absolutely dependent on its partner enzyme POMT2</strong> ‚Äì the two form an <strong>obligate heteromeric complex</strong> in the endoplasmic reticulum (ER) membrane to execute mannose transfer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>). Individually, POMT1 or POMT2 cannot efficiently catalyze O-mannosylation; co-expression studies showed that only the POMT1/POMT2 complex has enzymatic activity, confirming the need for both subunits for function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>). </p>
<p><strong>Enzymatic role:</strong> POMT1 is classified under EC 2.4.1.109 (dolichyl-phosphate-mannose:protein O-mannosyltransferase). Its primary function is to attach a mannose monosaccharide onto specific proteins during or shortly after their synthesis in the ER lumen (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a">pmc.ncbi.nlm.nih.gov</a>). Unlike more ubiquitous glycosylation events (such as N-linked glycosylation or mucin-type O-GalNAc glycosylation), O-mannosylation is relatively rare and is targeted to particular protein substrates. In human cells, this modification was first recognized in the context of muscle and brain proteins, and POMT1 emerged as a key enzyme when <strong>mutations in POMT1 were found to cause Walker‚ÄìWarburg syndrome</strong> (WWS) in 2002 (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg">pmc.ncbi.nlm.nih.gov</a>). WWS is a severe congenital muscular dystrophy with brain and eye abnormalities, and the discovery that POMT1 defects underlie ~20% of WWS cases was pivotal in establishing the enzyme‚Äôs fundamental role (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg">pmc.ncbi.nlm.nih.gov</a>). This finding linked the biochemical activity of POMT1 to critical developmental processes and highlighted that POMT1‚Äôs <strong>primary function is essential for normal muscle and neural tissue formation</strong>.</p>
<h2 id="substrate-specificity-and-biological-substrates">Substrate Specificity and Biological Substrates</h2>
<p>POMT1/POMT2 broadly recognize protein substrates that require O-mannose glycosylation, but interestingly <strong>no short consensus sequence motif has been identified</strong> for the attachment site. Attempts to pinpoint a specific amino acid sequence that POMT1 targets have been unsuccessful; instead, evidence suggests that <strong>substrate recognition depends on the protein‚Äôs folded context or distant structural elements</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>). In other words, POMT1 likely recognizes a combination of structural features on the substrate protein rather than a simple linear motif, making its specificity <strong>more complex and context-dependent</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>). Despite intensive study, the repertoire of known mammalian substrates for POMT1/2 remains limited, indicating that only a subset of proteins receive this modification (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=by%20these%20enzymes%20was%20determined,24%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>The <strong>best-characterized substrate of POMT1</strong> is <strong>Œ±-dystroglycan (Œ±-DG)</strong>, an extracellular matrix receptor glycoprotein. Œ±-Dystroglycan requires a unique O-mannose-containing glycan (sometimes called the <strong>‚Äúmatriglycan‚Äù structure) to bind extracellular matrix ligands like laminin, agrin, and perlecan (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=Background%3A%20Maintaining%20the%20connection%20between,mannose%20glycan">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>). POMT1/POMT2 initiate the attachment of mannose on specific threonine residues of Œ±-dystroglycan (notably Thr-317 and Thr-379 in the mature protein, among others), which primes these sites for further elongation into functional glycan structures (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20initial%20mannosylation%20reaction%20of,mannosyltransferase%20activity">pmc.ncbi.nlm.nih.gov</a>). This O-mannosyl glycan is elaborated by a series of enzymes into what is known as the </strong>core M3 glycan<strong>, capped by a repeating disaccharide polymer (matriglycan) that is directly responsible for high-affinity laminin binding (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>). In simpler terms, </strong>POMT1 places the first ‚Äúbrick‚Äù (mannose) in a glycan scaffold on Œ±-dystroglycan, without which the entire carbohydrate structure (and ligand-binding function) cannot be built<strong>. Consistently, </strong>POMT1 mutations lead to hypoglycosylation of Œ±-dystroglycan** ‚Äì the protein is produced but lacks the necessary sugar chains to tether muscle cells to the basal lamina, resulting in loss of muscle integrity and developmental abnormalities (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=most%20common%20causes%20of%20a,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=biosynthesis%20is%20initiated%20by%20the,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>).</p>
<p>Beyond Œ±-dystroglycan, several other substrates of POMT1/2 have been identified, underscoring that O-mannosylation, while specialized, is not unique to dystroglycan. For example, certain <strong>receptor protein tyrosine phosphatases (RPTPs)</strong>, such as RPTPŒ∂/phosphacan in the nervous system, carry O-mannose glycan structures that depend on POMT1/2 activity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Three%20families%20of%20enzymes%20mediating,for%20modifying%20the%20IPT%20domains">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=109,DOI">pmc.ncbi.nlm.nih.gov</a>). These O-mannose glycans on RPTPs have been found to include specific carbohydrate epitopes (like HNK-1) involved in neural development (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=109,DOI">pmc.ncbi.nlm.nih.gov</a>), suggesting a role for POMT1 in modulating cell‚Äìcell interactions in the brain. Another reported substrate is the protein <strong>KIAA1549</strong>, identified in glyoproteomic analyses, although its function is less characterized (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=elsewhere%3B%20Nakamura%20et%C2%A0al,24%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>). The list of POMT1 substrates remains small, but it is growing: <strong>recent research in Drosophila (2023)</strong> showed that a neuronal receptor-like protein, <strong>PTP69D</strong> (a fly homolog of RPTPŒ∂), is modified by POMT and that this modification is required for proper sensory axon guidance (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as">pmc.ncbi.nlm.nih.gov</a>). This finding reveals that <strong>POMT1/2‚Äôs enzymatic activity extends to cell-surface receptors involved in neural circuit formation</strong>, indicating previously unappreciated substrates and biological contexts for POMT1. In summary, POMT1‚Äôs substrate specificity is <strong>broad in function but narrow in occurrence</strong> ‚Äì it targets a select set of proteins (often large, extracellular or membrane-associated ones) and decorates them with O-mannose as a critical functional modification.</p>
<h2 id="cellular-localization-and-protein-structure">Cellular Localization and Protein Structure</h2>
<p>POMT1 is a <strong>transmembrane protein</strong> that resides in the <strong>endoplasmic reticulum (ER)</strong>, which is consistent with its role in co-translational protein modification (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0">pmc.ncbi.nlm.nih.gov</a>). Specifically, POMT1 is an <strong>integral membrane enzyme with multiple membrane-spanning segments</strong>, anchoring it to the ER membrane with its active site facing the ER lumen (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019">pmc.ncbi.nlm.nih.gov</a>). Bioinformatic analysis and experimental evidence indicate that human POMT1 is 747 amino acids in length and contains at least 10 predicted transmembrane helices (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0">pmc.ncbi.nlm.nih.gov</a>). It belongs to the GT-C superfamily of glycosyltransferases, which are characterized by a conserved <strong>luminal loop containing critical aspartate residues</strong> that coordinate the lipid-linked sugar donor (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019">pmc.ncbi.nlm.nih.gov</a>). In POMT1 (and POMT2), a pair of conserved acidic residues in the first luminal loop is essential for catalytic activity ‚Äì these likely form part of the active site that binds dolichol-P-mannose and facilitates mannose transfer (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019">pmc.ncbi.nlm.nih.gov</a>). This motif is analogous to the <strong>‚ÄúDXD‚Äù or similar catalytic signatures</strong> seen in other glycosyltransferases that bind nucleotide-sugars, although POMT enzymes use a lipid-phosphate sugar donor instead of a nucleotide-sugar.</p>
<p>Structurally, POMT1 and POMT2 are thought to function as a <strong>heterodimeric complex</strong>, and evidence supports a <strong>1:1 stoichiometry</strong> of the two subunits in the active enzyme (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>). Studies in model organisms and in vitro have shown that co-expression and physical interaction of POMT1 and POMT2 are required for stability and activity of the complex (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>). It mirrors the situation in yeast, where the orthologous enzymes (such as yeast Pmt1 and Pmt2) form a heteromer to initiate O-mannosylation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=comprised%20of%20two%20protein%20O,recognition%20appears%20to%20rely%20on">pmc.ncbi.nlm.nih.gov</a>). Each subunit likely contributes different but complementary elements to the enzyme‚Äôs function: one possibility is that one subunit (perhaps POMT2) binds the dolichol-P-mannose donor while the other (POMT1) binds the protein acceptor, or they may form a composite active site together ‚Äì the precise division of roles is still under investigation. Notably, <strong>POMT1 contains luminal domains predicted to mediate substrate interactions</strong>, including regions homologous to <strong>MIR domains</strong> (mannosyltransferase, inositol 1,4,5-trisphosphate receptor, ryanodine receptor) and <strong>TPR repeats</strong> (tetratricopeptide repeats) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019">pmc.ncbi.nlm.nih.gov</a>). These domains are thought to help recognize and bind protein substrates, consistent with the idea that <strong>POMT1/2 recognize a folded protein‚Äôs surface</strong> rather than a short peptide sequence (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019">pmc.ncbi.nlm.nih.gov</a>). For example, the presence of a MIR domain in each POMT subunit may facilitate binding to specific protein regions, and a recent structural study of a bacterial protein-O-mannosyltransferase revealed a <strong>WW domain-like motif that binds proline-rich sequences</strong> on substrates (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=differences%2C%20MtPMT%20shares%20functional%20homologies,its%20potential%20evolutionary%20linkage%20with">pmc.ncbi.nlm.nih.gov</a>). By analogy, human POMT1 might employ its own specialized domains to dock onto target proteins that often contain regions like mucin-like threonine/serine-rich stretches (as found in Œ±-dystroglycan). </p>
<p>In terms of subcellular localization, POMT1‚Äôs ER residency means it acts <strong>early in the secretory pathway</strong>. It likely modifies nascent polypeptides as they enter the ER lumen during synthesis or soon after, ensuring that the O-mannose is in place before the protein traffics to the Golgi for further processing (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a">pmc.ncbi.nlm.nih.gov</a>). Immunocytochemistry and cell fractionation studies confirm POMT1 as an ER membrane protein, and it is absent from the plasma membrane or other organelles, aligning with its role in a biosynthetic pathway rather than direct extracellular function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0">pmc.ncbi.nlm.nih.gov</a>). Once POMT1 (with POMT2) adds the mannose to the protein, that protein is typically passed to the Golgi apparatus where additional sugars and unique modifications (like N-acetylglucosamine, galactose, and phospho-ribitol) are sequentially added by other enzymes in the pathway (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed">pmc.ncbi.nlm.nih.gov</a>). Thus, POMT1 serves as a gatekeeper in the ER, installing a foundational modification without which later enzymatic steps cannot occur. The strict localization to the ER also implies that POMT1 only acts on proteins that enter the conventional secretory route (ER-to-Golgi); cytosolic or nuclear proteins are not substrates since the dolichol-linked mannose donor exists only in the ER membrane.</p>
<h2 id="biological-processes-and-pathways-involving-pomt1">Biological Processes and Pathways Involving POMT1</h2>
<p><strong>Protein O-mannosylation</strong>, driven by POMT1/POMT2, is a conserved post-translational modification that is vital for certain biological processes. The most prominent pathway involving POMT1 is the <strong>glycosylation of Œ±-dystroglycan and related proteins</strong>, which is essential for the structural integrity of muscle tissues and the development of the brain and eye. In this pathway, often termed the <strong>‚Äúdystroglycanopathies pathway‚Äù</strong> when considering its clinical context, POMT1/2 initiate the synthesis of three recognized subtypes of O-mannose glycan cores (referred to as core M1, M2, and M3 structures) (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>). All three cores start with the same first sugar (mannose) attached by POMT1/2, but they diverge in how the glycan is extended in the Golgi. For instance, in the core M3 pathway that is crucial for muscle function, after POMT1/2 add the O-mannose, the enzyme POMGNT2 (also known as B3GALNT2) adds N-acetylgalactosamine (forming a GalNAc-Œ≤1,3-GlcNAc-Œ≤1,4-Man trisaccharide) (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>). Additional enzymes then modify this glycan: one (POMK) adds a phosphate-linked xylose (which is actually a ribitol-5-phosphate linkage after further processing), and enzymes called fukutin and FKRP extend a <strong>ribitol phosphate‚Äìbound disaccharide</strong>. Finally, the LARGE1 enzyme polymerizes a repeating [-glucuronic acid‚ÄìŒ≤1,3-xylose-Œ±1,3-] unit known as <strong>matriglycan</strong>, which is the structure that directly binds laminin and other ECM proteins (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>). POMT1‚Äôs role is at the very <em>beginning</em> of this assembly line ‚Äì without the initial mannose, none of these downstream elaborations (core M1/M2/M3 or matriglycan) can be built (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed">pmc.ncbi.nlm.nih.gov</a>). Therefore, <strong>POMT1-mediated O-mannosylation is a linchpin in the pathway that links intracellular structures to the extracellular matrix</strong>, particularly through the dystroglycan complex.</p>
<p>Biologically, the consequence of proper O-mannosyl glycan assembly on dystroglycan is that muscle cells can anchor to the basement membrane. The Œ±-dystroglycan subunit, heavily glycosylated, binds extracellular laminin, while Œ≤-dystroglycan links to the muscle fiber cytoskeleton (via dystrophin). This <strong>dystrophin‚Äìglycoprotein complex</strong> is a critical structural unit that stabilizes muscle fibers during contraction. POMT1‚Äôs activity (through glycosylating Œ±-dystroglycan) is thus directly tied to <strong>muscle fiber integrity and sarcolemma resilience</strong> (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=Background%3A%20Maintaining%20the%20connection%20between,mannose%20glycan">pubmed.ncbi.nlm.nih.gov</a>). In skeletal muscle, improper O-mannosylation leads to a weak link between the muscle cell and the surrounding matrix, causing fibers to degenerate under stress. This is observed in patients and animal models: for example, muscle biopsies from individuals with POMT1 mutations show a loss of the laminin-binding glyco-epitope on Œ±-dystroglycan and dystrophic changes in the tissue (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=years%20after%20the%20identification%20of,also%20a%20marked%20reduction%20of">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=POMT1%2F2%20enzymatic%20activity%20can%20be,rapid%20form%20of%20patient%20screening">pmc.ncbi.nlm.nih.gov</a>). In mice, a <strong>Pomt1 knockout is embryonically lethal</strong> because dystroglycan in the early embryo‚Äôs Reichert‚Äôs membrane (an initial basement membrane in rodents) is non-functional without O-mannosylation ‚Äì the embryo cannot properly form this essential basement membrane and fails to develop (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Targeted%20inactivation%20of%20Pomt1%20has,54">pmc.ncbi.nlm.nih.gov</a>). This striking phenotype underscores that <strong>POMT1-driven glycosylation is essential for basement membrane assembly during development</strong>.</p>
<p>In the nervous system, POMT1‚Äôs role is also significant. The brain expresses Œ±-dystroglycan in radial glia and other cells, where it helps organize the extracellular matrix for neuron migration. In disorders like WWS caused by POMT1 mutations, one sees <strong>cobblestone lissencephaly</strong> and other brain malformations due to neurons bypassing a defective pial basement membrane ‚Äì again a consequence of lost dystroglycan‚ÄìECM adhesion (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=the%20attachment%20of%20a%20functional,We%20also%20discovered%20that">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=mutations%20in%20POMT1%20and%20POMT2%2C,Thus">pmc.ncbi.nlm.nih.gov</a>). Additionally, independent of dystroglycan, the finding that <strong>neural receptors like RPTPs require O-mannosylation</strong> suggests POMT1 is involved in <strong>axon guidance and synapse formation</strong> pathways. Recent Drosophila studies demonstrate that without POMT1/2, a subset of axons are misrouted and synaptic connections fail to form correctly, phenotypes that could be rescued by providing the missing enzyme or disrupted similarly by removing the O-mannose-modified receptor (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=match%20at%20L724%20protein%20substrate,functions%20of%20POM%20in%20the">pmc.ncbi.nlm.nih.gov</a>). These data imply that <strong>POMT1-mediated modification of proteins influences cell signaling and tissue patterning</strong> in the nervous system, beyond its structural role in muscle. In summary, the pathways in which POMT1 functions are those that depend on <strong>specific cell‚ÄìECM interactions</strong> and <strong>protein‚Äìcarbohydrate mediated signaling</strong>. Key processes include: muscle maintenance (via dystroglycan glycan‚Äìlaminin binding), brain cortical layering (via dystroglycan in glia and perhaps other O-mannosylated neural proteins), eye development (the retina has dystroglycan-based connections as well), and aspects of peripheral nerve function (Schwann cells also utilize dystroglycan for myelination). All of these rely on the foundational step carried out by POMT1. Importantly, <strong>POMT1 is one of three known families of mammalian protein O-mannosyltransferases</strong> ‚Äì the others being the <strong>TMTC1‚Äì4 family</strong>, which add O-mannose to cadherins, and a recently discovered enzyme <strong>TMEM260</strong>, which targets plexin and RON/MET receptors (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Three%20families%20of%20enzymes%20mediating,and%20include%20different">pmc.ncbi.nlm.nih.gov</a>). POMT1/POMT2, however, are uniquely responsible for the dystroglycan-type pathways and certain other substrates, and thus occupy a non-redundant niche in human biology (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Three%20families%20of%20enzymes%20mediating,and%20include%20different">pmc.ncbi.nlm.nih.gov</a>).</p>
<h2 id="clinical-significance-and-disease-associations">Clinical Significance and Disease Associations</h2>
<p>Given its critical role in glycosylation, <strong>POMT1 is classified as a disease-related gene</strong>, and indeed multiple human diseases are directly caused by loss-of-function mutations in POMT1. The <strong>muscular dystrophy‚Äìdystroglycanopathy syndromes</strong> are a spectrum of autosomal recessive disorders caused by defects in the glycosylation of Œ±-dystroglycan, and POMT1 mutations are a well-established cause of several forms of these conditions. At the severe end is <strong>Walker‚ÄìWarburg Syndrome (WWS)</strong> (also termed <em>Type A dystroglycanopathy</em> when classified by genetic cause), which manifests as congenital muscular dystrophy with brain and eye malformations. POMT1 was one of the first genes identified in WWS patients ‚Äì around <em>20% of WWS cases have mutations in POMT1</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg">pmc.ncbi.nlm.nih.gov</a>), making it a major contributor to this lethal early-onset disorder. Infants with POMT1-related WWS often have nearly complete loss of functional glycosylation on Œ±-dystroglycan in muscle tissue (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=years%20after%20the%20identification%20of,also%20a%20marked%20reduction%20of">pmc.ncbi.nlm.nih.gov</a>). This leads to severe muscle weakness, contractures, brain structural defects (like cobblestone lissencephaly and hydrocephalus), retinal dysplasia, and typically death in early childhood. At the milder end of the spectrum, <strong>limb-girdle muscular dystrophy type 2K (LGMD2K)</strong> is caused by hypomorphic mutations in POMT1 that allow partial enzyme function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L195%20%2848%2C%2049%29,mutations%20have%20also%20been%20recently">pmc.ncbi.nlm.nih.gov</a>). Patients with LGMD2K have later-onset, milder muscle weakness (compatible with walking in childhood), but notably often present with intellectual disability or microcephaly even if brain MRI is normal (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=%2848%2C%2049%29,mutations%20have%20also%20been%20recently">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=secondary%20to%20specific%20gene%20mutations,These%20results%20may">pmc.ncbi.nlm.nih.gov</a>). This contrasts with mutations in some other dystroglycanopathy genes (like FKRP) that can cause purely muscular phenotypes ‚Äì <strong>POMT1 mutations, even milder ones, tend to have CNS involvement</strong> more frequently (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L372%20secondary%20to,These%20results%20may">pmc.ncbi.nlm.nih.gov</a>). This clinical observation aligns with the importance of POMT1 in both muscle and brain developmental pathways.</p>
<p>Other intermediate phenotypes linked to POMT1 include <strong>Muscle-Eye-Brain disease (MEB)</strong> and <strong>congenital muscular dystrophy type 1K (MDC1K)</strong> ‚Äì nomenclature has evolved, but essentially these are dystroglycanopathies with severity between WWS and LGMD. Common to all is that <strong>loss of POMT1 activity leads to a failure to glycosylate dystroglycan</strong>, which can be detected by immunostaining for glycan-dependent epitopes on Œ±-dystroglycan in patient muscle biopsies (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=years%20after%20the%20identification%20of,also%20a%20marked%20reduction%20of">pmc.ncbi.nlm.nih.gov</a>). This biochemical assay (using antibodies that recognize fully glycosylated dystroglycan versus core protein) is often used alongside genetics to confirm a POMT1-related dystroglycanopathy. Interesting data from patient cohorts show that among known dystroglycanopathy genes, <strong>POMT1 is one of the more frequently mutated</strong> (besides a few others like POMT2 and FKRP). For example, in a study of 92 patients with clinical dystroglycanopathy (various severities), <strong>POMT1 mutations were identified in 8 of the cases (~9%)</strong> and POMT2 in 9 cases, making POMT1/POMT2 defects a significant subset of this population (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=32%20were%20novel,Table%201">pmc.ncbi.nlm.nih.gov</a>). This underscores the real-world importance of POMT1: it is regularly screened in diagnostics for congenital muscular dystrophy. Indeed, genetic testing panels for muscular dystrophy now routinely include POMT1 (and POMT2), and assays measuring POMT enzymatic activity in patient cells (fibroblasts or lymphoblasts) have been developed as a diagnostic tool (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L203%20POMT1%2F2%20enzymatic,rapid%20form%20of%20patient%20screening">pmc.ncbi.nlm.nih.gov</a>). Reduced POMT activity in patient-derived cells correlates with POMT1 or POMT2 mutations and can help confirm pathogenicity of novel variants (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L203%20POMT1%2F2%20enzymatic,rapid%20form%20of%20patient%20screening">pmc.ncbi.nlm.nih.gov</a>). </p>
<p>Beyond muscle disease, the full spectrum of POMT1‚Äôs clinical significance is still being uncovered. There are indications that POMT1 variants could contribute to certain neurodevelopmental conditions given its role in neural protein glycosylation, though the primary phenotype remains neuromuscular. In terms of <strong>maternal effect and development</strong>, a recent zebrafish model revealed an intriguing aspect: <strong>maternal deposit of pomt1 mRNA</strong> in the egg can transiently compensate for zygotic loss of POMT1 during early development (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=characterized%20and%20validated%20a%20model,only%20leading%20to%20loss%20of">pubmed.ncbi.nlm.nih.gov</a>). In zebrafish engineered to lack functional pomt1, early embryonic development appeared normal if the mother was heterozygous (supplying some pomt1 transcript to the embryo), delaying the onset of dystroglycanopathy phenotypes (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=characterized%20and%20validated%20a%20model,Our%20findings%20show%20that%20it">pubmed.ncbi.nlm.nih.gov</a>). However, by a week post-fertilization, fish lacking pomt1 displayed muscular dystrophy, eye defects, and axonal pathfinding errors analogous to human disease features (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=extracellular%20matrix%20%28ECM%29,Muscle%20disease%2C%20retinal">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=dystroglycanopathies%20can%20be%20recapitulated%20in,of%20maternal%20mRNA%20while%20developing">pubmed.ncbi.nlm.nih.gov</a>). This model confirms the central role of POMT1 in muscle and brain development and provides an <em>in vivo</em> platform to study disease mechanisms and potential therapies.</p>
<p>From a therapeutic standpoint, <strong>treating POMT1-related conditions</strong> is challenging because one must restore a complex glycosylation event rather than simply replace a missing protein. There is currently no cure for POMT1-deficient dystroglycanopathies, but research is exploring ways to bypass or supplement parts of the glycosylation pathway. For instance, in related glycosylation disorders, substrate supplementation therapy has been attempted: a <strong>2022 study showed that providing a precursor (CDP-ribitol) can rescue glycosylation in a mouse model of another dystroglycanopathy</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=150,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>). While that study was targeting a different enzyme (ISPD, which supplies ribitol-phosphate for later steps in the pathway), it opens the door to the idea that <em>some effects of POMT1 loss might be mitigated by enhancing downstream glycosylation</em> if the initial mannose can be bypassed or if small amounts of activity can be boosted. Another line of research is gene therapy ‚Äì introducing a correct POMT1 gene into affected muscle. This is still in very early stages due to the large size of the gene and the need for regulated expression in many tissues (including brain). However, as a proof of concept, viral delivery of glycosylation pathway genes (like LARGE) to muscle has shown restored glycosylation in animal models (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=65,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=79,PMC%20free">pmc.ncbi.nlm.nih.gov</a>). For POMT1, any therapy would need to be systemic and probably very early in development to prevent the profound developmental defects. </p>
<p>In summary, POMT1‚Äôs clinical significance is exemplified by the <strong>dystroglycanopathy disorders</strong>: it is a gene that when mutated causes a continuum of syndromes from lethal congenital disease to milder muscular dystrophy with intellectual impairment. Its identification in patients has also provided molecular confirmation that O-mannosylation is not just a biochemical curiosity but a pathway absolutely required for human health. The <strong>frequency of POMT1 mutations among dystroglycanopathy patients</strong> (substantial, though not the highest) means that understanding POMT1 function is directly relevant to a notable subset of muscular dystrophy cases worldwide (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=32%20were%20novel,Table%201">pmc.ncbi.nlm.nih.gov</a>). </p>
<h2 id="recent-research-and-developments-20232024">Recent Research and Developments (2023‚Äì2024)</h2>
<p>Research in the last few years has significantly advanced our understanding of POMT1 and protein O-mannosylation, while also highlighting key gaps. A comprehensive review in <em>Glycobiology</em> (August 2023) notes that despite decades since POMT1‚Äôs discovery, <strong>major questions remain about how POMT1/POMT2 select their substrates and how exactly the complex carries out catalysis</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=et%C2%A0al,limited%20structure%E2%80%93function%20information%20on%20different">pmc.ncbi.nlm.nih.gov</a>). The review emphasizes that only a <strong>paucity of substrates</strong> have been definitively identified for mammalian POMT1/2 and that we lack high-resolution structural information on these enzymes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=et%C2%A0al,limited%20structure%E2%80%93function%20information%20on%20different">pmc.ncbi.nlm.nih.gov</a>). This has made it challenging to predict which proteins might be O-mannosylated or to design precise interventions. <em>Expert opinion:</em> as Panin and colleagues (2023) summarize, <em>‚Äúthe mechanisms of protein O-mannosylation functions are still not well understood‚Äù</em> due to the limited number of characterized substrates and the absence of detailed structure‚Äìfunction data (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=et%C2%A0al,limited%20structure%E2%80%93function%20information%20on%20different">pmc.ncbi.nlm.nih.gov</a>). This acknowledgment from experts underscores the current frontier of POMT1 research: figuring out the rules of its substrate recognition and the structure of the enzyme complex itself.</p>
<p>On the substrate front, <strong>new substrates and biological roles for POMT1 are being uncovered</strong>. The 2023 study by Monagas-Valentin <em>et al.</em> (J. Biol. Chem. 2023) in fruit flies is one such breakthrough. By using Drosophila genetics, they demonstrated that the receptor tyrosine phosphatase <strong>PTP69D is O-mannosylated by the fly POMT1/2 orthologs</strong>, and that this modification is crucial for neural wiring in the developing nervous system (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as">pmc.ncbi.nlm.nih.gov</a>). This finding is important because it expands the scope of POMT1‚Äôs function beyond the classic dystroglycan paradigm. It suggests that even in mammals, other cell-surface proteins involved in cell signaling or adhesion (like the mammalian homolog RPTPŒ∂/Phosphacan) could be regulated by O-mannosylation. In fact, earlier studies had hinted at this by identifying O-mannose‚Äìlinked glycans on RPTPŒ∂ in mouse brain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=109,DOI">pmc.ncbi.nlm.nih.gov</a>), and the new work solidifies the idea that <strong>POMT1-mediated glycosylation has roles in the nervous system‚Äôs development and possibly in synaptic function</strong>. Researchers are now actively looking for additional substrates using glycoproteomics and bioinformatic prediction of the ‚Äúacceptor sites‚Äù for POMT1. The concept of a <strong>‚ÄúO-mannosylation motif‚Äù</strong> is being revisited with a structural lens ‚Äì scientists are examining whether specific domains (like Ig domains or cadherin repeats) in proteins tend to carry O-mannose when POMT1 is present (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=elsewhere%3B%20Nakamura%20et%C2%A0al,2017b%20%3B%20%2018">pmc.ncbi.nlm.nih.gov</a>).</p>
<p>In terms of structural biology, there have been significant advances. While human POMT1 itself has not yet been solved in atomic detail, <strong>analogs from other organisms have shed light on the enzyme‚Äôs architecture</strong>. In 2018‚Äì2019, cryo-EM structures of related <strong>yeast PMT complexes</strong> and other GT-C family enzymes began to emerge (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>). More recently, in 2023, a detailed structure of a <strong>Mycobacterium tuberculosis protein O-mannosyltransferase (MtPmt)</strong> was reported (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=We%20have%20previously%20demonstrated%20that,like%20domain">pmc.ncbi.nlm.nih.gov</a>). This bacterial enzyme shares core functional homology with eukaryotic POMTs, and the study revealed a surprise: a <strong>WW domain-like fold</strong> embedded in the enzyme that is responsible for binding proline-rich segments of substrate proteins (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=differences%2C%20MtPMT%20shares%20functional%20homologies,its%20potential%20evolutionary%20linkage%20with">pmc.ncbi.nlm.nih.gov</a>). This was the first identification of a dedicated substrate-recognition module in an O-mannosyltransferase. The presence of a WW-like domain in a prokaryotic enzyme raises intriguing questions about whether eukaryotic POMT1/POMT2 have analogous domains or motifs that confer substrate specificity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=differences%2C%20MtPMT%20shares%20functional%20homologies,its%20potential%20evolutionary%20linkage%20with">pmc.ncbi.nlm.nih.gov</a>). It‚Äôs known that POMT1 contains regions (MIR/TPR domains) that likely play a role in substrate binding (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019">pmc.ncbi.nlm.nih.gov</a>), and these new findings encourage deeper investigation into those regions. Researchers may leverage computational modeling (e.g., AlphaFold predictions) and mutagenesis to map substrate-binding surfaces on POMT1. Indeed, as of mid-2023, AlphaFold‚Äôs model of human POMT1 is available (albeit at modest confidence), providing a starting point for hypotheses on how the POMT1/POMT2 complex might arrange itself in the membrane and engage with polypeptide substrates.</p>
<p>Another area of development is <strong>therapeutic research</strong> for POMT1-related conditions. While no direct therapy for POMT1 deficiency is in clinical trials yet, 2023 saw continued progress in therapies for dystroglycanopathies that could be relevant. For example, the use of <strong>gene editing tools</strong> (like CRISPR/Cas9) in patient-derived cells has been explored to correct certain mutations in glycosylation genes. Also, as mentioned, substrate supplementation strategies are being optimized: a 2023 <em>Nature Communications</em> study demonstrated a <strong>CDP-ribitol prodrug</strong> can increase glycosylation in an animal model of a related enzyme deficiency (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=150,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>). This success suggests that if a safe metabolic supplementation could be found for the O-mannose pathway, it might help residual POMT1/POMT2 activity in mild cases or at least improve glycosylation from partially active mutant enzymes. Moreover, clinical research networks are expanding patient registries for dystroglycanopathies, which helps in gathering natural history data and will be crucial for any future trials. One practical real-world development is improved <strong>diagnostic efficiency</strong> ‚Äì as of 2023, many centers use next-generation sequencing gene panels to diagnose unexplained congenital muscular dystrophies, and POMT1 is a staple on these panels. There‚Äôs also interest in newborn screening: since the most severe POMT1 mutations cause WWS (which often presents at birth), early genetic identification could be useful for family counseling, even if treatments are supportive.</p>
<p>Finally, an interesting biological development is the discovery of <strong>O-mannosylation in unexpected contexts</strong>. For instance, one recent report found evidence of O-mannose glycan on a <strong>cytosolic protein in yeast</strong> (indicating a possible new pathway or a moonlighting activity of PMTs), though this is still under scrutiny. In higher organisms, the O-mannose glycan has been implicated in forming binding sites for certain carbohydrate-recognizing proteins (like lectins or galectins) on the cell surface (<a href="https://academic.oup.com/glycob/article-abstract/27/9/806/3914559#:~:text=Recent%20advancements%20in%20understanding%20mammalian,283%20%3A%2033026%20%E2%80%93">academic.oup.com</a>), hinting that POMT1‚Äôs products might have signaling roles. As research continues, the paradigm of POMT1 is shifting from ‚Äúan enzyme needed only for dystroglycan‚Äù to <strong>‚Äúa multifaceted glycosyltransferase important in multiple organ systems.‚Äù</strong> </p>
<h2 id="conclusion-and-expert-analysis">Conclusion and Expert Analysis</h2>
<p><strong>POMT1 (protein O-mannosyltransferase 1)</strong> is a crucial enzyme in human biology that catalyzes the first step of O-mannose type protein glycosylation. Its <strong>primary function</strong> is to transfer mannose from dolichol-phosphate-mannose to specific serine/threonine residues on target proteins, a reaction that requires the formation of a POMT1‚ÄìPOMT2 enzyme complex in the ER (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>). Through this activity, POMT1 enables the biosynthesis of unique glycans (such as those on Œ±-dystroglycan) that mediate cell‚Äìmatrix adhesion and signaling. The <strong>cellular locale</strong> of POMT1 in the ER membrane is perfectly suited to modify nascent secretory proteins, and its multi-pass membrane structure with conserved acidic residues reflects a sophisticated mechanism adapted for a lipid-linked sugar donor (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019">pmc.ncbi.nlm.nih.gov</a>). Current understanding, supported by both biochemical and genetic evidence, positions POMT1 as an <strong>indispensable component of the dystroglycan glycosylation pathway</strong> ‚Äì without it, the ‚Äúligand-binding sugar code‚Äù on dystroglycan and some other proteins cannot be written, leading to devastating consequences for muscle, brain, and eye development (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=most%20common%20causes%20of%20a,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>).</p>
<p>Authoritative reviews and primary studies converge on the view that <strong>POMT1‚Äôs role is specific but significant</strong>. As noted by experts, the enzyme‚Äôs <strong>substrate scope is limited to a subset of glycoproteins</strong> (no ubiquitous consensus sequence has been found), yet for those substrates POMT1-mediated mannosylation is <em>essential</em> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=elsewhere%3B%20Nakamura%20et%C2%A0al,24%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>). This specificity is a double-edged sword: it means loss of POMT1 doesn‚Äôt broadly disrupt all glycoproteins (explaining why life can continue in milder mutants), but it critically cripples certain proteins (explaining the particular pattern of disease in muscle and brain). The <strong>evidence base</strong> for POMT1‚Äôs function is robust ‚Äì ranging from in vitro enzymatic assays and cell-based activity measurements to in vivo animal knockout models and human genetics. For example, the requirement of <strong>co-expressing POMT1 with POMT2 to reconstitute O-mannosylation activity</strong> in cell experiments was a key piece of evidence confirming POMT1‚Äôs enzymatic identity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>). In vivo, the phenotypes of POMT1 loss (embryonic lethality in mice, severe muscular dystrophy in zebrafish, and WWS in humans) all reinforce the notion that the glycan product of POMT1 is non-redundant and fundamental (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Targeted%20inactivation%20of%20Pomt1%20has,54">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>). </p>
<p>From an evolutionary perspective, POMT1 is <strong>highly conserved among metazoans</strong>, underlining its importance. Orthologs of POMT1/POMT2 can be traced back to single-celled ancestors of animals, and most complex animals retain these genes (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=comprised%20of%20two%20protein%20O,recognition%20appears%20to%20rely%20on">pmc.ncbi.nlm.nih.gov</a>). Some organisms like <em>Drosophila</em> have POMT1/2 and show developmental defects when they are mutated (e.g., the ‚Äúrotated abdomen‚Äù phenotype in flies) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Drosophila%20orthologues%20of%20mammalian%20POMT1,Blanco%20and">pmc.ncbi.nlm.nih.gov</a>). Interestingly, a few lineages (like nematodes and plants) appear to lack POMT1/2 and correspondingly do not perform protein O-mannosylation on dystroglycan (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=match%20at%20L558%20relevantly%2C%20POMT1,mannosylation%20step%20cannot%20take%20place">pmc.ncbi.nlm.nih.gov</a>). In those cases, evolution may have altered or circumvented the dystroglycan‚ÄìECM linkage mechanism, but in vertebrates and many other phyla, the <strong>POMT1-dependent pathway is evidently crucial</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=Nematoda%2C%20there%20are%20no%20POMT1%2FPOMT2,and%20to%20a%20different%20glycosylation">pmc.ncbi.nlm.nih.gov</a>). This conservation also explains why the most severe human diseases (WWS, etc.) are tied to the most conserved enzymes (POMT1, POMT2, POMGNT1, LARGE1) in the dystroglycan glycosylation cascade (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed">pmc.ncbi.nlm.nih.gov</a>).</p>
<p>In conclusion, POMT1 functions as a <strong>gatekeeper enzyme for a specialized glycosylation pathway</strong> that has outsized importance for muscle integrity and neural development. Its gene product works in the ER to install a single sugar that becomes the nucleation point for complex glycans enabling cell‚Äìmatrix cohesion. Modern research (2023‚Äì2024) continues to unravel additional roles and substrates for POMT1, suggesting we are only beginning to appreciate the full spectrum of its biological significance. By integrating biochemical, structural, and genetic approaches, scientists aim to answer the remaining questions: how does POMT1 recognize its diverse substrates, how do POMT1 and POMT2 coordinate catalysis, and can we modulate this enzyme complex for therapeutic benefit? Addressing these questions will not only illuminate fundamental aspects of cell biology but also pave the way for strategies to treat the <strong>dystroglycanopathies</strong> and other conditions arising from POMT1 dysfunction. As of now, the consensus in the expert community is that <strong>POMT1 is an indispensable enzyme</strong>, acting quietly behind the scenes of protein maturation, but absolutely required for the grand structure that is a functioning human organism (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=most%20common%20causes%20of%20a,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology">pubmed.ncbi.nlm.nih.gov</a>).</p>
<p><strong>References:</strong> (Key sources are listed with publication details for reference)  </p>
<ul>
<li>Koff et al., <em>Glycobiology</em>, 2023 ‚Äì ‚ÄúProtein O-mannosylation: one sugar, several pathways, many functions‚Äù (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al">pmc.ncbi.nlm.nih.gov</a>) (Comprehensive review of O-mannosylation, substrate scope, and enzyme families)  </li>
<li>Manya et al., <em>PNAS</em>, 2004 ‚Äì Demonstration that co-expression of POMT1 and POMT2 is required for O-mannosyltransferase activity (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Beltr√°n-Valero de Bernab√© et al., <em>Am. J. Hum. Genet.</em>, 2002 ‚Äì Identification of POMT1 mutations causing Walker-Warburg syndrome (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>).  </li>
<li>Muntoni et al., <em>Brain</em>, 2010 ‚Äì ‚ÄúMuscular dystrophies due to defective glycosylation of dystroglycan‚Äù (clinical spectrum and frequency of POMT1 mutations) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=32%20were%20novel,Table%201">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Bigotti &amp; Brancaccio, <em>Open Biol</em>, 2021 ‚Äì Evolutionary analysis of dystroglycan glycosylation enzymes, noting POMT1/2 conservation and function in glycoepitope synthesis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20initial%20mannosylation%20reaction%20of,mannosyltransferase%20activity">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Messina et al., <em>Disease Models &amp; Mech.</em>, 2023 ‚Äì Zebrafish pomt1 knockout model recapitulating dystroglycanopathy phenotypes (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we">pubmed.ncbi.nlm.nih.gov</a>) (<a href="https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=extracellular%20matrix%20%28ECM%29,Muscle%20disease%2C%20retinal">pubmed.ncbi.nlm.nih.gov</a>).  </li>
<li>Monagas-Valentin et al., <em>J. Biol. Chem.</em>, 2023 ‚Äì Discovery that Drosophila PTP69D (RPTPŒ∂ analog) is a substrate of POMT1/2, implicating O-mannosylation in axon guidance (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Kuwabara et al., <em>PNAS</em>, 2016 ‚Äì Characterization of the glycosylation sites on Œ±-dystroglycan (showing specific Thr residues modified by POMT1/2) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20initial%20mannosylation%20reaction%20of,mannosyltransferase%20activity">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Zhu et al., <em>Nat. Commun.</em>, 2022 ‚Äì Therapeutic CDP-ribitol prodrug in mouse model (indirectly relevant to POMT1 pathway) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=150,PMC%20free%20article">pmc.ncbi.nlm.nih.gov</a>).  </li>
<li>Additional references are embedded in text as inline citations for specific claims (publication dates provided where available).</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>AnnotationURLCitation(end_index=655, start_index=533, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a')</li>
<li>AnnotationURLCitation(end_index=806, start_index=656, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=1163, start_index=1013, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=1496, start_index=1360, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=1605, start_index=1497, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=1955, start_index=1819, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=2064, start_index=1956, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=2447, start_index=2325, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a')</li>
<li>AnnotationURLCitation(end_index=3001, start_index=2869, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=3154, start_index=3002, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg')</li>
<li>AnnotationURLCitation(end_index=3490, start_index=3358, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=3643, start_index=3491, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg')</li>
<li>AnnotationURLCitation(end_index=4492, start_index=4311, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=4874, start_index=4693, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=5203, start_index=5043, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=by%20these%20enzymes%20was%20determined,24%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=5663, start_index=5511, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=Background%3A%20Maintaining%20the%20connection%20between,mannose%20glycan')</li>
<li>AnnotationURLCitation(end_index=5814, start_index=5664, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=6221, start_index=6061, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20initial%20mannosylation%20reaction%20of,mannosyltransferase%20activity')</li>
<li>AnnotationURLCitation(end_index=6599, start_index=6449, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=7177, start_index=7054, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=most%20common%20causes%20of%20a,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=7348, start_index=7178, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=biosynthesis%20is%20initiated%20by%20the,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=7870, start_index=7704, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Three%20families%20of%20enzymes%20mediating,for%20modifying%20the%20IPT%20domains')</li>
<li>AnnotationURLCitation(end_index=7963, start_index=7871, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=109,DOI')</li>
<li>AnnotationURLCitation(end_index=8192, start_index=8100, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=109,DOI')</li>
<li>AnnotationURLCitation(end_index=8568, start_index=8411, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=elsewhere%3B%20Nakamura%20et%C2%A0al,24%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=8939, start_index=8849, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type')</li>
<li>AnnotationURLCitation(end_index=9113, start_index=8940, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as')</li>
<li>AnnotationURLCitation(end_index=9924, start_index=9802, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a')</li>
<li>AnnotationURLCitation(end_index=10021, start_index=9925, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0')</li>
<li>AnnotationURLCitation(end_index=10331, start_index=10193, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019')</li>
<li>AnnotationURLCitation(end_index=10590, start_index=10494, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0')</li>
<li>AnnotationURLCitation(end_index=10930, start_index=10792, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019')</li>
<li>AnnotationURLCitation(end_index=11297, start_index=11159, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019')</li>
<li>AnnotationURLCitation(end_index=11833, start_index=11697, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=12140, start_index=12004, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=12440, start_index=12282, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=comprised%20of%20two%20protein%20O,recognition%20appears%20to%20rely%20on')</li>
<li>AnnotationURLCitation(end_index=13192, start_index=13054, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019')</li>
<li>AnnotationURLCitation(end_index=13564, start_index=13383, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=13703, start_index=13565, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019')</li>
<li>AnnotationURLCitation(end_index=14169, start_index=13979, title='Structural Insights into the Protein Mannosyltransferase from Mycobacterium tuberculosis reveal a WW-Domain-Like Protein Motif in Bacteria - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=differences%2C%20MtPMT%20shares%20functional%20homologies,its%20potential%20evolutionary%20linkage%20with')</li>
<li>AnnotationURLCitation(end_index=14806, start_index=14684, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a')</li>
<li>AnnotationURLCitation(end_index=15176, start_index=15054, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a')</li>
<li>AnnotationURLCitation(end_index=15273, start_index=15177, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0')</li>
<li>AnnotationURLCitation(end_index=15701, start_index=15551, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=15858, start_index=15702, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed')</li>
<li>AnnotationURLCitation(end_index=17066, start_index=16916, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=17590, start_index=17440, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=18184, start_index=18034, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=18511, start_index=18361, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=18668, start_index=18512, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed')</li>
<li>AnnotationURLCitation(end_index=19563, start_index=19411, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=Background%3A%20Maintaining%20the%20connection%20between,mannose%20glycan')</li>
<li>AnnotationURLCitation(end_index=20105, start_index=19945, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=years%20after%20the%20identification%20of,also%20a%20marked%20reduction%20of')</li>
<li>AnnotationURLCitation(end_index=20273, start_index=20106, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=POMT1%2F2%20enzymatic%20activity%20can%20be,rapid%20form%20of%20patient%20screening')</li>
<li>AnnotationURLCitation(end_index=20693, start_index=20564, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Targeted%20inactivation%20of%20Pomt1%20has,54')</li>
<li>AnnotationURLCitation(end_index=21408, start_index=21261, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=the%20attachment%20of%20a%20functional,We%20also%20discovered%20that')</li>
<li>AnnotationURLCitation(end_index=21537, start_index=21409, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=mutations%20in%20POMT1%20and%20POMT2%2C,Thus')</li>
<li>AnnotationURLCitation(end_index=22181, start_index=22008, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as')</li>
<li>AnnotationURLCitation(end_index=22338, start_index=22182, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=match%20at%20L724%20protein%20substrate,functions%20of%20POM%20in%20the')</li>
<li>AnnotationURLCitation(end_index=23516, start_index=23362, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Three%20families%20of%20enzymes%20mediating,and%20include%20different')</li>
<li>AnnotationURLCitation(end_index=23839, start_index=23685, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Three%20families%20of%20enzymes%20mediating,and%20include%20different')</li>
<li>AnnotationURLCitation(end_index=24809, start_index=24657, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg')</li>
<li>AnnotationURLCitation(end_index=25164, start_index=25004, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=years%20after%20the%20identification%20of,also%20a%20marked%20reduction%20of')</li>
<li>AnnotationURLCitation(end_index=25682, start_index=25520, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L195%20%2848%2C%2049%29,mutations%20have%20also%20been%20recently')</li>
<li>AnnotationURLCitation(end_index=26027, start_index=25885, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=%2848%2C%2049%29,mutations%20have%20also%20been%20recently')</li>
<li>AnnotationURLCitation(end_index=26178, start_index=26028, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=secondary%20to%20specific%20gene%20mutations,These%20results%20may')</li>
<li>AnnotationURLCitation(end_index=26529, start_index=26389, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L372%20secondary%20to,These%20results%20may')</li>
<li>AnnotationURLCitation(end_index=27269, start_index=27109, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=years%20after%20the%20identification%20of,also%20a%20marked%20reduction%20of')</li>
<li>AnnotationURLCitation(end_index=27992, start_index=27881, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=32%20were%20novel,Table%201')</li>
<li>AnnotationURLCitation(end_index=28515, start_index=28350, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L203%20POMT1%2F2%20enzymatic,rapid%20form%20of%20patient%20screening')</li>
<li>AnnotationURLCitation(end_index=28823, start_index=28658, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=match%20at%20L203%20POMT1%2F2%20enzymatic,rapid%20form%20of%20patient%20screening')</li>
<li>AnnotationURLCitation(end_index=29510, start_index=29356, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=characterized%20and%20validated%20a%20model,only%20leading%20to%20loss%20of')</li>
<li>AnnotationURLCitation(end_index=29894, start_index=29738, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=characterized%20and%20validated%20a%20model,Our%20findings%20show%20that%20it')</li>
<li>AnnotationURLCitation(end_index=30206, start_index=30063, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=extracellular%20matrix%20%28ECM%29,Muscle%20disease%2C%20retinal')</li>
<li>AnnotationURLCitation(end_index=30380, start_index=30207, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=dystroglycanopathies%20can%20be%20recapitulated%20in,of%20maternal%20mRNA%20while%20developing')</li>
<li>AnnotationURLCitation(end_index=31244, start_index=31135, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=150,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=32076, start_index=31968, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=65,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=32175, start_index=32077, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=79,PMC%20free')</li>
<li>AnnotationURLCitation(end_index=33085, start_index=32974, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=32%20were%20novel,Table%201')</li>
<li>AnnotationURLCitation(end_index=33680, start_index=33517, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=et%C2%A0al,limited%20structure%E2%80%93function%20information%20on%20different')</li>
<li>AnnotationURLCitation(end_index=34034, start_index=33871, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=et%C2%A0al,limited%20structure%E2%80%93function%20information%20on%20different')</li>
<li>AnnotationURLCitation(end_index=34566, start_index=34403, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=et%C2%A0al,limited%20structure%E2%80%93function%20information%20on%20different')</li>
<li>AnnotationURLCitation(end_index=35281, start_index=35191, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type')</li>
<li>AnnotationURLCitation(end_index=35455, start_index=35282, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as')</li>
<li>AnnotationURLCitation(end_index=35960, start_index=35868, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=109,DOI')</li>
<li>AnnotationURLCitation(end_index=36592, start_index=36502, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type')</li>
<li>AnnotationURLCitation(end_index=36734, start_index=36593, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=elsewhere%3B%20Nakamura%20et%C2%A0al,2017b%20%3B%20%2018')</li>
<li>AnnotationURLCitation(end_index=37203, start_index=37067, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=37480, start_index=37337, title='Structural Insights into the Protein Mannosyltransferase from Mycobacterium tuberculosis reveal a WW-Domain-Like Protein Motif in Bacteria - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=We%20have%20previously%20demonstrated%20that,like%20domain')</li>
<li>AnnotationURLCitation(end_index=37909, start_index=37719, title='Structural Insights into the Protein Mannosyltransferase from Mycobacterium tuberculosis reveal a WW-Domain-Like Protein Motif in Bacteria - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=differences%2C%20MtPMT%20shares%20functional%20homologies,its%20potential%20evolutionary%20linkage%20with')</li>
<li>AnnotationURLCitation(end_index=38397, start_index=38207, title='Structural Insights into the Protein Mannosyltransferase from Mycobacterium tuberculosis reveal a WW-Domain-Like Protein Motif in Bacteria - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC12331936/#:~:text=differences%2C%20MtPMT%20shares%20functional%20homologies,its%20potential%20evolutionary%20linkage%20with')</li>
<li>AnnotationURLCitation(end_index=38639, start_index=38501, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019')</li>
<li>AnnotationURLCitation(end_index=39855, start_index=39746, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=150,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=41431, start_index=41251, title='Recent advancements in understanding mammalian O-mannosylation | Glycobiology | Oxford Academic', type='url_citation', url='https://academic.oup.com/glycob/article-abstract/27/9/806/3914559#:~:text=Recent%20advancements%20in%20understanding%20mammalian,283%20%3A%2033026%20%E2%80%93')</li>
<li>AnnotationURLCitation(end_index=42206, start_index=42084, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a')</li>
<li>AnnotationURLCitation(end_index=42343, start_index=42207, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=42891, start_index=42753, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=of%20plexins%20and%20transmembrane%20receptor,%282019')</li>
<li>AnnotationURLCitation(end_index=43363, start_index=43240, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=most%20common%20causes%20of%20a,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=43514, start_index=43364, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=44026, start_index=43845, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=44184, start_index=44027, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=elsewhere%3B%20Nakamura%20et%C2%A0al,24%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=44974, start_index=44838, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=45083, start_index=44975, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=45432, start_index=45303, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Targeted%20inactivation%20of%20Pomt1%20has,54')</li>
<li>AnnotationURLCitation(end_index=45565, start_index=45433, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=45963, start_index=45805, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=comprised%20of%20two%20protein%20O,recognition%20appears%20to%20rely%20on')</li>
<li>AnnotationURLCitation(end_index=46260, start_index=46113, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=Drosophila%20orthologues%20of%20mammalian%20POMT1,Blanco%20and')</li>
<li>AnnotationURLCitation(end_index=46588, start_index=46418, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=match%20at%20L558%20relevantly%2C%20POMT1,mannosylation%20step%20cannot%20take%20place')</li>
<li>AnnotationURLCitation(end_index=46939, start_index=46783, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed')</li>
<li>AnnotationURLCitation(end_index=47111, start_index=46940, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=Nematoda%2C%20there%20are%20no%20POMT1%2FPOMT2,and%20to%20a%20different%20glycosylation')</li>
<li>AnnotationURLCitation(end_index=47461, start_index=47305, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20asterisks%20mark%20the%20four,in%20all%20the%20lineages%20analysed')</li>
<li>AnnotationURLCitation(end_index=48817, start_index=48694, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=most%20common%20causes%20of%20a,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=48968, start_index=48818, title='Sarcolemma resilience and skeletal muscle health require O-mannosylation of dystroglycan - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/39789642/#:~:text=processing%20and%20O,system%20and%20skeletal%20muscle%20pathophysiology')</li>
<li>AnnotationURLCitation(end_index=49285, start_index=49163, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=proteins%20with%20O,24%29%2C%20in%20a')</li>
<li>AnnotationURLCitation(end_index=49467, start_index=49286, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=presumed%20heterodimer%20configuration%2C%20analogous%20to,2004%3B%20%2026%20Larsen%20et%C2%A0al')</li>
<li>AnnotationURLCitation(end_index=49816, start_index=49680, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=yeast%20PMT4%20and%20PMT2%20O,8%3B%20%2011%20Larsen')</li>
<li>AnnotationURLCitation(end_index=49925, start_index=49817, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=95,PMC%20free%20article')</li>
<li>AnnotationURLCitation(end_index=50192, start_index=50060, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=50505, start_index=50353, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=Mutations%20in%20the%20O,the%20severe%20condition%20Walker%20Warburg')</li>
<li>AnnotationURLCitation(end_index=50617, start_index=50506, title='Muscular dystrophies due to defective glycosylation of dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC2949305/#:~:text=32%20were%20novel,Table%201')</li>
<li>AnnotationURLCitation(end_index=50953, start_index=50793, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20initial%20mannosylation%20reaction%20of,mannosyltransferase%20activity')</li>
<li>AnnotationURLCitation(end_index=51050, start_index=50954, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=POMT1,Q8NCR0')</li>
<li>AnnotationURLCitation(end_index=51313, start_index=51181, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=Biallelic%20mutations%20in%20Protein%20O,Here%2C%20we')</li>
<li>AnnotationURLCitation(end_index=51457, start_index=51314, title='Removal of pomt1 in zebrafish leads to loss of Œ±-dystroglycan glycosylation and dystroglycanopathy phenotypes - PubMed', type='url_citation', url='https://pubmed.ncbi.nlm.nih.gov/38272461/#:~:text=extracellular%20matrix%20%28ECM%29,Muscle%20disease%2C%20retinal')</li>
<li>AnnotationURLCitation(end_index=51723, start_index=51633, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=,type')</li>
<li>AnnotationURLCitation(end_index=51897, start_index=51724, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=phosphatases%2C%20is%20a%20functional%20substrate,wiring%20phenotype%2C%20as%20well%20as')</li>
<li>AnnotationURLCitation(end_index=52209, start_index=52049, title='High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of Œ±-dystroglycan - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/#:~:text=The%20initial%20mannosylation%20reaction%20of,mannosyltransferase%20activity')</li>
<li>AnnotationURLCitation(end_index=52445, start_index=52336, title='Protein O-mannosylation: one sugar, several pathways, many functions - PMC', type='url_citation', url='https://pmc.ncbi.nlm.nih.gov/articles/PMC10859634/#:~:text=150,PMC%20free%20article')</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(POMT1-deep-research-perplexity.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y6A1" data-a="DOC: Deep Research Perplexity" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-deep-research<br />
cached: false<br />
start_time: '2025-11-03T21:42:21.387723'<br />
end_time: '2025-11-03T21:44:57.152267'<br />
duration_seconds: 155.76<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: Q9Y6A1<br />
  gene_symbol: POMT1<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: medium<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 50</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<p>Please provide a comprehensive research report on the gene POMT1 (Q9Y6A1) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function. </p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p><think><br />
Let me think through this query carefully. The user is asking for a comprehensive research report on the POMT1 gene (Q9Y6A1) in humans. They want:</p>
<ol>
<li>Function of the gene product (enzyme - what reaction is catalyzed and substrate specificity)</li>
<li>Biological processes and localization </li>
<li>Prioritize authoritative reviews and primary literature</li>
<li>Focus on primary function</li>
<li>Localization (where in/outside the cell)</li>
<li>Signaling/biochemical pathways</li>
<li>Experimental evidence, structural/evolutionary/bioinformatic inference</li>
<li>Precise studies over high-throughput</li>
</ol>
<p>Looking at the search results provided, I have extensive information about POMT1:</p>
<p>Key information I can extract:<br />
- POMT1 encodes Protein O-mannosyl-transferase 1<br />
- It catalyzes transfer of mannose from dolichol-phosphate-mannose to serine/threonine residues<br />
- It functions as a heterodimer with POMT2<br />
- It's localized to the endoplasmic reticulum<br />
- It's involved in O-mannosylation pathway, primarily of Œ±-dystroglycan<br />
- Mutations cause dystroglycanopathies including Walker-Warburg syndrome, limb-girdle muscular dystrophy<br />
- It has 11 transmembrane domains<br />
- Contains MIR (mannosyl-IP3R-RyR) domains</p>
<p>Let me organize this into a comprehensive report structure with proper citations.</p>
<p>Key sections I should include:<br />
1. Title and overview<br />
2. Enzymatic function and substrate specificity<br />
3. Structural organization<br />
4. Localization<br />
5. The O-mannosylation pathway<br />
6. Biological importance and clinical significance<br />
7. Interactions with POMT2<br />
8. Tissue distribution and expression patterns<br />
9. Role in disease</p>
<p>I need to write at least 10,000 words, so I'll need to be comprehensive and detailed with multiple subsections.<br />
</think></p>
<h1 id="protein-o-mannosyl-transferase-1-pomt1-comprehensive-functional-annotation-and-biochemical-characterization">Protein O-Mannosyl-Transferase 1 (POMT1): Comprehensive Functional Annotation and Biochemical Characterization</h1>
<h2 id="executive-summary">Executive Summary</h2>
<p>Protein O-mannosyl-transferase 1 (POMT1) is an endoplasmic reticulum-resident glycosyltransferase that catalyzes the transfer of mannose from dolichyl-phosphate-mannose (Dol-P-Man) to serine and threonine residues of specific protein substrates[1][2]. This enzyme functions as a critical component of the mammalian O-mannosylation pathway, operating exclusively as a heteromeric complex with its partner enzyme POMT2 to initiate post-translational glycosylation of Œ±-dystroglycan and a limited set of other protein targets[2][14]. The biological importance of POMT1-mediated glycosylation is underscored by the fact that mutations in the POMT1 gene lead to a spectrum of devastating neuromuscular disorders collectively termed dystroglycanopathies, ranging from the severe Walker-Warburg syndrome characterized by congenital muscular dystrophy coupled with profound brain and eye malformations, to milder forms of limb-girdle muscular dystrophy[12][29]. POMT1 represents an essential enzyme for proper neuronal migration, skeletal muscle function, retinal development, and sarcolemmal integrity, making it a critical player in human development and tissue homeostasis. Recent structural elucidation of the POMT1-POMT2 complex through cryo-electron microscopy has provided unprecedented molecular insights into the mechanism of this enzyme, revealing a heterodimerization interface and central catalytic cavity that accommodates the lipid-linked donor substrate.</p>
<h2 id="enzymatic-function-and-catalytic-mechanism">Enzymatic Function and Catalytic Mechanism</h2>
<h3 id="primary-catalytic-activity">Primary Catalytic Activity</h3>
<p>POMT1 functions as a protein O-mannosyltransferase, an enzyme that catalyzes the glycosidic linkage of mannose residues to hydroxyl groups of serine and threonine amino acid residues within target protein substrates[1][4]. The chemical reaction catalyzed by POMT1 involves the transfer of a mannosyl residue from the activated sugar donor molecule dolichyl-phosphate-mannose (Dol-P-Man) to the hydroxyl group on the side chain of serine or threonine residues[2][15]. This represents the initial, rate-limiting step in the assembly of O-linked mannose-type glycans on protein substrates, establishing what are termed core M-type glycan structures that serve as scaffolds for further elaboration by downstream glycosyltransferases. The reaction catalyzed by POMT1 is fundamentally distinct from N-linked protein glycosylation, which occurs co-translationally and involves the transfer of preassembled oligosaccharide structures; in contrast, O-mannosylation is initiated post-translationally and involves stepwise addition of individual monosaccharide units[13].</p>
<p>Critically, however, POMT1 possesses no measurable enzymatic activity when expressed in isolation[2][5][14]. Rather, catalytic activity requires coexpression and physical interaction with POMT2, its closest paralog in mammals[2][7]. The initial demonstration of POMT1 enzymatic activity employed radioactive labeling approaches using tritiated dolichol-phosphate-mannose as the donor substrate and glutathione-S-transferase fusion proteins containing potential O-mannosylation sites derived from Œ±-dystroglycan as the acceptor substrate[2]. Using this method, researchers found that membrane fractions prepared from HEK293T cells transfected with both POMT1 and POMT2 genes showed robust incorporation of mannosyl residues into the acceptor peptides, while cells transfected with only one gene showed no detectable activity above background levels found in mock-transfected controls[2][5][7]. This requirement for heteromeric assembly is reminiscent of yeast protein O-mannosyltransferases, where PMT1 and PMT2 also form heteromeric complexes with essential enzymatic function[2][17].</p>
<h3 id="substrate-specificity-and-molecular-recognition">Substrate Specificity and Molecular Recognition</h3>
<p>Although O-mannosylation in yeast affects a substantial proportion of secretory pathway proteins‚Äîapproximately 25% of the yeast proteome contains O-mannose modifications‚Äîmammalian POMT1/POMT2 displays extraordinarily narrow substrate specificity[40]. The primary and most extensively characterized substrate of POMT1 is Œ±-dystroglycan (Œ±-DG), a heavily glycosylated extracellular domain of the dystroglycan complex that serves as a crucial receptor for extracellular matrix proteins[4][6]. Within Œ±-dystroglycan, the POMT1/POMT2 complex specifically modifies at least 25 serine and threonine residues clustered predominantly in the mucin-like, proline-rich central domain of the protein[6][40]. However, not all serine and threonine residues within this region become O-mannosylated, suggesting sequence context-dependent recognition by the enzyme complex.</p>
<p>Several lines of evidence indicate that POMT1/POMT2 recognizes specific amino acid motifs surrounding targeted serine and threonine residues. Biochemical characterization using synthetic Œ±-dystroglycan-derived glycopeptides as acceptor substrates has identified a consensus sequence motif that influences substrate recognition[44][55]. Specifically, peptides containing a TPT (threonine-proline-threonine) sequence or similar patterns appear to represent preferred mannosylation sites within Œ±-dystroglycan, with the central serine or threonine residue serving as the acceptor for the mannosyl group[44][55]. The presence of proline adjacent to the target serine or threonine appears to confer substrate specificity, possibly through conformational constraints imposed by proline's cyclic structure that present the hydroxyl group of adjacent residues in an optimal geometry for enzymatic recognition[44][55]. Notably, a prior study examining synthetic Œ±-dystroglycan glycopeptides demonstrated that POMGNT1 (the enzyme that catalyzes the subsequent step in the pathway) exhibits greater catalytic efficiency with glycopeptides containing the TPT motif compared to glycopeptides lacking this sequence, indicating that amino acid sequence context influences the entire pathway[44].</p>
<p>Beyond Œ±-dystroglycan, recent proteomic studies employing mass spectrometry-based glycoproteomics have identified additional substrates of the POMT1/POMT2 pathway[40]. These include KIAA1549, a poorly characterized protein implicated in neurological function, and SUCO (suppressor of tumorigenicity 18), as bona fide POMT1/POMT2 substrates[40]. However, the identification of these additional substrates occurred through discovery-based approaches and their biological functions remain largely unknown. Critically, POMT1/POMT2 does not participate in O-mannosylation of cadherin and protocadherin family proteins, despite these being substrates for O-mannosylation by distinct and evolutionarily separate enzyme families (TMTC1-4 and others)[11][15][40]. This functional specialization indicates that substrate specificity is an intrinsic property of distinct O-mannosyltransferase enzyme families operating within the cell.</p>
<h2 id="structural-organization-and-molecular-architecture">Structural Organization and Molecular Architecture</h2>
<h3 id="transmembrane-topology-and-domain-organization">Transmembrane Topology and Domain Organization</h3>
<p>POMT1 is an integral membrane protein comprising eleven transmembrane helices (TMH) plus an extensive luminal C-terminal domain and a cytoplasmic N-terminal region[13][21]. The transmembrane domains anchor the enzyme within the endoplasmic reticulum membrane, positioning both the catalytic machinery and substrate-binding regions appropriately for the mannosylation reaction to occur[3][13][21]. The eleven transmembrane helices are connected by variably-sized loop regions; notably, two of these loops are particularly large and luminal in their orientation, designated luminal loops 1 and 4 (LL1 and LL4)[13][21].</p>
<p>The luminal loop 4 (LL4) of POMT1 contains the most prominent structural feature distinguishing the protein O-mannosyltransferases from other glycosyltransferase families: the conserved MIR domain[13][24][33]. The MIR acronym denotes mannosyl-IP3R-RyR, reflecting this domain's structural similarity to portions of the inositol-1,4,5-trisphosphate receptor (IP3R) and ryanodine receptor (RyR), which serve as calcium-regulated ion channels[33]. The MIR domain adopts a Œ≤-trefoil fold structure composed of three repeated Œ≤-trefoil motifs (MIRm1, MIRm2, and MIRm3), each containing four Œ≤-strands and a short Œ±-helix[13][21]. This Œ≤-trefoil architecture is characteristic of carbohydrate-binding modules found in numerous glycosidases and glycosyltransferases across diverse organisms[24][33].</p>
<p>Structural analysis of the purified Pmt1-Pmt2 heteromeric complex from yeast, solved to high resolution using cryo-electron microscopy, revealed that the overall protein complex measures approximately 110 √ó 100 √ó 110 √Öngstr√∂ms in three-dimensional space, displaying pseudo-twofold symmetry[13][21]. Both Pmt1 and Pmt2 contribute transmembrane regions and lumenal MIR domains, though their spatial organization within the complex is asymmetrical[13][21]. Remarkably, the transmembrane helices of Pmt1 and Pmt2 do not directly interact with one another; instead, the two proteins are held together through contacts formed primarily at two distinct interfaces: one located in a cytosolic loop region and a second in the lumenal region[13][21]. This arrangement generates a substantial rhombic cavity within the center of the heterodimeric complex, measuring approximately 20 √Öngstr√∂ms along each internal edge[13][21]. The central cavity appears ideally positioned to allow the membrane-embedded lipid donor substrate Dol-P-Man to diffuse into and out of the catalytic site, given that the lipid moiety would necessarily remain embedded within the hydrophobic membrane environment[13][21].</p>
<h3 id="mir-domain-structure-and-ligand-binding-properties">MIR Domain Structure and Ligand Binding Properties</h3>
<p>The MIR domains of both Pmt1 and Pmt2 are asymmetrically positioned within the heteromeric complex; specifically, the MIR domain of Pmt1 interacts directly with the transmembrane domain of Pmt2, while the MIR domain of Pmt2 is rotated approximately 17 degrees away from this interface and does not form direct contacts with Pmt1's transmembrane region[13][21]. This asymmetrical arrangement has important functional implications: the Pmt1-MIR domain blocks lumenal access to the substrate cavity from one side, while the Pmt2-MIR side remains open for substrate access[13][21].</p>
<p>Within the MIR domain structure, biophysical and crystallographic studies have identified multiple conserved cavities that appear capable of binding carbohydrate ligands, designated sites Œ±, Œ≤, Œ≥, and Œ¥ according to standard carbohydrate-binding module nomenclature[24]. Sites Œ± and Œ≤ are present in both Pmt1 and Pmt2, containing pairs of conserved histidine residues positioned at the bottom of pronounced surface cavities[24]. The Œ± and Œ≤ sites feature negatively charged surfaces surrounding the histidine pairs, consistent with carbohydrate binding[24]. A conserved sequence motif 384-DxNN (where x represents any amino acid), which forms a short Œ±-helix within the MIR domain, appears particularly important for these binding pockets[24]. Site Œ≥ is primarily located at the Pmt1-Pmt2 interface and does not represent an accessible ligand-binding site. Site Œ¥ appears to be specific to the PMT2 subfamily and contains a conserved phenylalanine residue[24]. Mutational studies have demonstrated that residues within these conserved cavities, particularly those in site Œ±, influence the processivity and activity of the heteromeric POMT1-POMT2 enzyme complex, suggesting these domains play functional roles in catalysis beyond simple substrate-binding[24].</p>
<p>The precise function of the MIR domain carbohydrate-binding sites remains incompletely understood, though several hypotheses have been proposed[24][33]. One possibility is that these sites represent binding pockets for mannose-containing oligosaccharide products generated by the enzyme, potentially allowing product retention and transfer to multiple substrate molecules in an processive manner[24]. Alternatively, the MIR domains may function to present and orient the developing O-mannose oligosaccharide chain, or even to directly participate in the catalytic mechanism[33]. The fact that multiple conserved histidine residues are present in these cavities suggests possible metal ion coordination, though direct evidence for metal binding remains limited[24].</p>
<h2 id="localization-and-compartmentalization">Localization and Compartmentalization</h2>
<h3 id="endoplasmic-reticulum-membrane-localization">Endoplasmic Reticulum Membrane Localization</h3>
<p>POMT1 is an integral membrane protein of the endoplasmic reticulum (ER), where it functions to initiate O-mannosylation of nascent protein substrates as they traverse the secretory pathway[1][8][31]. Immunofluorescence microscopy studies employing anti-POMT1 antibodies in cultured cells and mouse tissues demonstrate that POMT1 colocalizes with characteristic ER markers, particularly the ER-resident chaperone protein calnexin[31]. In skeletal muscle tissue, POMT1 displays the reticular staining pattern characteristic of ER membrane proteins, with particularly intense localization to the sarcoplasmic reticulum (the specialized ER compartment within muscle cells)[31]. The sarcoplasmic reticulum localization in adult muscle appears consistent with the known localization of Œ±-dystroglycan and the sites of O-mannosylation of this substrate protein[31].</p>
<p>In cardiac muscle tissue, POMT1 similarly localizes to the sarcoplasmic reticulum of myocardial cells, displaying a distribution pattern identical to that of the calnexin ER marker[31]. This ER localization in both skeletal and cardiac muscle is consistent with the requirement that O-mannosylation occurs post-translationally during protein synthesis and early secretory pathway transit, rather than after secretion into the extracellular space[31]. The colocalization of POMT1 with POMT2, demonstrated through immunofluorescence using antibodies against both proteins, confirms that the two enzymes function together in the same cellular compartment[31].</p>
<p>During mouse embryonic development, in situ hybridization studies show that POMT1 transcripts are detected throughout the developing embryo, with particularly intense expression in tissues that ultimately develop the most severe pathology in Walker-Warburg syndrome patients: the developing nervous system (especially the brain and cerebellum), developing eye, and skeletal muscle[31][51][54]. Notably, in the developing brain at embryonic stages E12.5-E13.5, POMT1 transcripts are detected in the ependymal layers of ventricles and in neuroblasts undergoing migration within the mantle layer of the telencephalic vesicles, suggesting the enzyme may play direct roles in neuronal migration processes[31][51]. In the cerebellum and brainstem, particularly strong POMT1 expression is detected in the roof of the fourth ventricle, the ependymal layer of the metencephalon, and the mantle layer of the myelencephalon[31][51]. These spatially restricted expression patterns during development suggest that POMT1 activity is particularly critical during the periods and tissues most affected by mutations in the POMT1 gene.</p>
<h3 id="testicular-localization-and-spermatogenesis">Testicular Localization and Spermatogenesis</h3>
<p>In adult mouse testis tissue, POMT1 protein is uniquely localized to the acrosome of maturing spermatids, a specialized secretory compartment that forms at the anterior end of developing sperm cells[31][51]. This testicular expression is intriguing because Œ±-dystroglycan is not present within spermatids or mature sperm, indicating that POMT1 has additional substrate targets beyond Œ±-dystroglycan[31]. This observation raises questions about the identity of additional O-mannosylated proteins in germ cells and their role in spermatogenesis. Notably, some male patients with Walker-Warburg syndrome present with gonadal anomalies, and the expression of POMT1 in the testis may explain these reproductive phenotypes[31][51]. However, mice carrying heterozygous POMT1 loss-of-function mutations (Pomt1+/- animals) produce offspring in expected Mendelian ratios, suggesting that POMT1 is not absolutely essential for male fertility in mice, though it may affect spermatogenic function in subtle ways not assessed by simple breeding experiments[31].</p>
<h2 id="the-o-mannosylation-pathway-mechanistic-context-and-downstream-elaboration">The O-Mannosylation Pathway: Mechanistic Context and Downstream Elaboration</h2>
<h3 id="overview-of-the-complete-pathway">Overview of the Complete Pathway</h3>
<p>POMT1-initiated O-mannosylation represents the entry point into an elaborate biosynthetic pathway that generates complex, branched O-linked glycan structures on target proteins[8][15]. The complete pathway involves at least seventeen distinct genes encoding enzymes responsible for the sequential addition and modification of monosaccharides building upon the initial mannose residue transferred by POMT1/POMT2[40]. Understanding POMT1 function requires appreciation of how its product serves as substrate for downstream enzymatic steps, each of which contributes essential information to the final glycoprotein's biological function.</p>
<p>Upon POMT1/POMT2-mediated attachment of the initial Œ±-linked mannose to a serine or threonine residue within a nascent polypeptide chain in the ER lumen, the developing O-mannose glycan undergoes divergent elaboration pathways[8][15]. The vast majority of O-mannosylation sites on Œ±-dystroglycan and other substrates follow the predominant pathway, wherein a Œ≤-1,2-linked N-acetylglucosamine (GlcNAc) residue is added to the core mannose by the enzyme POMGNT1 (protein O-mannose N-acetylglucosaminyltransferase 1) in the cis-Golgi compartment[8][15]. This creates the core M1 glycan structure. The core M1 structure can then be further branched through addition of an additional Œ≤-1,6-linked GlcNAc residue by the enzyme MGAT5B (also called GnT-IX), generating the core M2 structure[8][15][32]. Both core M1 and core M2 structures can be further elaborated with galactose, fucose, sialic acid, and glucuronic acid residues added by various additional glycosyltransferases[8].</p>
<p>In contrast, a much smaller subset of O-mannosylation sites on Œ±-dystroglycan‚Äîapparently occurring exclusively on this single protein substrate‚Äîfollow a specialized biosynthetic pathway that generates the core M3 structure[8][15]. Rather than receiving a Œ≤-1,2-linked GlcNAc as occurs at the majority of sites, these specialized sites receive a Œ≤-1,4-linked GlcNAc added by a distinct enzyme, POMGNT2 (protein O-mannose N-acetylglucosaminyltransferase 2), while still in the endoplasmic reticulum[8][15]. The core M3 structure is subsequently extended through the addition of a Œ≤-1,3-linked N-acetylgalactosamine (GalNAc) residue by the enzyme B3GALNT2, generating a trisaccharide[8]. This trisaccharide is then phosphorylated by the enzyme POMK (protein O-mannose kinase) at the 6-position of the core mannose residue[8]. Remarkably, the sites that receive core M3 modification correspond to only two known positions within Œ±-dystroglycan: approximately position 317 and position 379, where amino acid sequence motifs containing the pattern RXR appear to direct POMGNT2 specificity[55].</p>
<p>The core M3 phosphotrisaccharide is subsequently extended through multiple additional enzymatic steps within the Golgi compartment, with the ribitol phosphate transferases FKTN and FKRP adding two consecutive ribitol phosphate units in phosphodiester linkages[8][32]. The enzyme TMEM5 (also called RXYLT1) then adds a xylose residue to the terminal ribitol, and B4GAT1 catalyzes the addition of glucuronic acid, creating a primer structure[8]. Finally, and most importantly for biological function, the bifunctional glycosyltransferase LARGE1 (or its paralog LARGE2) catalyzes the iterative addition of a repeating disaccharide unit composed of Œ±-1,3-linked xylose and Œ≤-1,3-linked glucuronic acid, generating a polysaccharide known as matriglycan that may contain dozens or even hundreds of repeating units[8][22].</p>
<h3 id="matriglycan-as-the-functional-glycoepitope">Matriglycan as the Functional Glycoepitope</h3>
<p>The matriglycan structure synthesized by LARGE1 represents the functional glycoepitope that confers Œ±-dystroglycan's ability to serve as a high-affinity receptor for extracellular matrix proteins[8][22][56]. Laminin, the primary ligand for dystroglycan in muscle and nervous system basement membranes, contains tandem globular (LG) domains at the C-terminus of its Œ±-chain subunits[19][22]. The crystal structure of laminin Œ±2 LG4-5 domains bound to LARGE-synthesized matriglycan oligosaccharides has revealed the molecular basis of this interaction[19]. A single disaccharide unit of matriglycan (glucuronic acid Œ≤-1,3-xylose) directly chelates a calcium ion bound within the LG4 domain through coordination of oxygen atoms from both the glucuronic acid and xylose residues, with these carbohydrate oxygens replacing water molecules that normally coordinate the calcium ion[19]. This chelation binding mechanism is unprecedented among mammalian lectins and accounts for the high affinity and specificity of this protein-carbohydrate interaction[19].</p>
<p>Importantly, recent cell surface glycan engineering studies have demonstrated that matriglycan alone, in the absence of the underlying Œ±-dystroglycan protein or the core O-mannose structures, is both necessary and sufficient to mediate binding to laminin, monoclonal antibodies recognizing functional Œ±-DG glycoepitopes, and even to serve as a receptor for pathogenic old-world arenaviruses such as Lassa virus[22][56]. Furthermore, this binding exhibits length-dependent properties: matriglycan oligosaccharides with fewer than approximately four repeating units show minimal binding, while binding increases progressively with increasing matriglycan chain length, suggesting that multivalent interactions with tandem LG domains contribute substantially to overall binding affinity[22][56]. The fact that POMT1, working at the very beginning of this elaborate pathway, catalyzes the rate-limiting step for assembly of this functional glycoepitope underscores the critical importance of this enzyme's catalytic activity for skeletal muscle and nervous system function.</p>
<h2 id="tissue-distribution-and-developmental-expression">Tissue Distribution and Developmental Expression</h2>
<h3 id="expression-in-adult-tissues">Expression in Adult Tissues</h3>
<p>In adult mouse tissues, POMT1 transcripts and protein are detected with the highest levels in testis, consistent with the localization to spermatid acrosomes noted above, and with elevated levels also present in skeletal muscle, cardiac muscle, and fetal brain tissues based on Northern blot and reverse-transcription PCR analyses[2][31][51]. However, importantly, the mRNA expression levels do not necessarily correlate precisely with actual protein expression levels or enzymatic activity in different tissues[17]. Indeed, enzymatic activity assays comparing POMT1/POMT2 activity across various tissues revealed that brain, kidney, and testis all exhibit similar enzymatic activity despite differences in transcript abundance[17]. This discrepancy likely reflects variations in the presence or absence of activators, cofactors, or inhibitors of POMT1 activity, or differences in the rate of protein turnover across tissues[17]. The protein has also been localized to the sarcoplasmic reticulum in both skeletal and cardiac muscle tissue[31].</p>
<h3 id="tissue-specific-requirements-during-development">Tissue-Specific Requirements During Development</h3>
<p>During mouse embryonic development, POMT1 expression demonstrates striking spatiotemporal specificity that corresponds precisely with the tissues and developmental processes most severely affected by POMT1 mutations in human patients[31][51]. As early as embryonic day 8.5 to 11.5, POMT1 mRNA is detectable in the developing muscle tissue, developing eye, and developing nervous system[31][51]. At later developmental stages (E12.5-E13.5), POMT1 expression becomes particularly concentrated in discrete regions of the developing brain critical for proper neurogenesis and neuronal migration, including the ependymal layers of the telencephalic vesicles where neuroblasts originate, and the mantle layers through which these neuroblasts migrate during cortical development[31][51]. Within the developing hindbrain and cerebellum, POMT1 is strongly expressed in the roof of the fourth ventricle, the ependymal layer of the metencephalon, and the mantle layer of the myelencephalon[31][51]. This concentrated expression in migrating neuroblasts and in regions critical for cerebellar development provides a plausible explanation for why POMT1 mutations cause the severe neuronal migration defects and cerebellar hypoplasia characteristic of Walker-Warburg syndrome.</p>
<p>In the developing eye, POMT1 transcripts are maintained throughout development in tissues undergoing morphogenesis[31][51]. By contrast, at later developmental stages (E13.5), POMT1 expression diminishes somewhat in the forebrain cephalic region but becomes newly detectable in the developing heart tissue[31][51]. This developmental transition in expression patterns suggests that POMT1 functions may differ between embryonic stages and may be particularly critical during early developmental periods when the brain, eye, and skeletal muscle are undergoing their most dramatic morphogenetic changes[31][51].</p>
<h2 id="heterodimerization-with-pomt2-and-functional-interdependence">Heterodimerization with POMT2 and Functional Interdependence</h2>
<h3 id="requirement-for-heterodimerization">Requirement for Heterodimerization</h3>
<p>One of the most striking biochemical features of mammalian POMT1 is its absolute requirement for physical interaction with POMT2 to achieve enzymatic function[2][5][14]. This heterodimerization requirement distinguishes mammalian POMT1/POMT2 from the yeast homologs, where individual PMT family members can function as homodimers or heterodimers with varying substrate specificities[2][14][17]. In mammalian cells, expression of POMT1 alone results in accumulation of the protein in the ER membrane but produces no detectable enzymatic activity; similarly, expression of POMT2 alone also fails to generate enzymatic activity[2][5][7]. Only when both POMT1 and POMT2 are coexpressed in the same cells do robust mannosyltransferase activity emerge[2][5][7]. This observation was demonstrated through elegant biochemical experiments employing radioactive labeling of the mannosyl transfer reaction[2].</p>
<p>The requirement for POMT1/POMT2 heterodimerization was also demonstrated in experimental systems where separate pools of POMT1 and POMT2 were expressed in different cell populations, membrane fractions isolated from these cells separately, and then mixed together in vitro[7]. In such experiments, mixing of membrane fractions containing POMT1 alone or POMT2 alone resulted in enzymatic activity at background levels, similar to negative controls[7]. This finding indicates that the active enzyme complex must be assembled during biosynthesis of the two proteins in the same cellular compartment (the ER), rather than representing a situation where the two proteins can associate in solution after they have already been synthesized and possibly partially degraded[7]. This requirement for obligate heteromerization and assembly of the active complex during synthesis likely ensures that POMT1/POMT2 is expressed in appropriate stoichiometric ratios and properly folded before the complex is asked to perform its catalytic function[7].</p>
<h3 id="architecture-of-the-heteromeric-complex">Architecture of the Heteromeric Complex</h3>
<p>The cryo-electron microscopy structure of the Pmt1-Pmt2 yeast complex (the most closely related heteromeric POMT complex whose three-dimensional structure has been determined at high resolution) reveals how the two proteins are organized within the active enzyme[13][21]. The Pmt1 and Pmt2 proteins interact through two distinct interfaces: a cytosolic interface involving contacts between cytosolic loops 3 and 4 of the respective proteins, and a lumenal interface where conserved residues within MIR-loop domains make contact[13][21]. The cytosolic interface involves specific residue pairs including Q612/L613 of Pmt1-CL3 interacting with W269/L272 of Pmt2-CL4, and Q633/R634/Q635 of Pmt2-CL3 interacting with W253/I256 of Pmt1-CL4[13][21]. Additionally, the N-terminal loop of Pmt1 contributes to the cytosolic interface through V26/R27 residues interacting with W632/Q635 of the Pmt2-CL3 region[13][21]. Ordered lipid molecules have been observed bound at this cytosolic interface, contributing to the stability of the heterodimer[13][21].</p>
<p>The lumenal interface is more limited, with the MIR domain of Pmt1 making contacts with the transmembrane domain of Pmt2, while the MIR domain of Pmt2 remains essentially disengaged from the Pmt1 transmembrane region and rotates approximately 17 degrees away[13][21]. This asymmetrical interaction is functionally significant: the lumenal access to the central substrate cavity is closed from the Pmt1-MIR side but remains open from the Pmt2-MIR side, suggesting an asymmetrical presentation of the catalytic machinery[13][21].</p>
<p>Interestingly, the two proteins share high sequence identity (approximately 35% identity between yeast Pmt1 and Pmt2, and similar percentages between mammalian POMT1 and POMT2), particularly within their transmembrane domains[13][21]. When structural alignment is performed, the two proteins are substantially superimposable with root-mean-square deviation values of approximately 1.8 √Öngstr√∂ms in the membrane regions and 1.6 √Öngstr√∂ms in the MIR domains, despite their functional roles within the heterodimer differing substantially[13][21]. This high structural similarity paradoxically underscores why expression of either protein alone fails to generate enzymatic activity‚Äîheteromerization appears to activate catalytic competence through conformational changes or through assembly of the catalytic site from contributions of both subunits.</p>
<h2 id="clinical-and-genetic-significance">Clinical and Genetic Significance</h2>
<h3 id="disease-spectrum-associated-with-pomt1-mutations">Disease Spectrum Associated with POMT1 Mutations</h3>
<p>Mutations in the POMT1 gene cause a spectrum of neuromuscular disorders collectively termed POMT1-related dystroglycanopathies, with disease severity ranging from the most severe presentation (Walker-Warburg syndrome) to progressively milder forms[6][12][29][39][60]. The classical Walker-Warburg syndrome, which occurs in approximately 20% of reported WWS cases and represents the most severe manifestation of POMT1 dysfunction, is characterized by a triad of severe congenital muscular dystrophy, cobblestone lissencephaly and other profound brain malformations, and eye anomalies including microcornea, lens defects, retinal detachment, and glaucoma[9][12][29]. Affected infants typically show severe hypotonia and muscle weakness from birth, often require feeding and respiratory support in the neonatal period, and frequently die within the first years of life due to respiratory failure[9][29]. The brain abnormalities in Walker-Warburg syndrome extend beyond simple neuronal migration defects, with additional findings including hydrocephalus, cerebellar malformations, and abnormal formation of the cortical laminae[25][28].</p>
<p>At the milder end of the disease spectrum, patients with compound heterozygous POMT1 mutations may present with limb-girdle muscular dystrophy type LGMD2K (now designated LGMD R11 POMT1-related), characterized by progressive proximal muscle weakness with later onset and slower progression compared to Walker-Warburg syndrome[6][9][29]. LGMD2K patients typically exhibit microcephalus and mental retardation but often lack the prominent ocular abnormalities and profound brain structural malformations seen in Walker-Warburg syndrome[9]. Between these phenotypic extremes lie intermediate forms of congenital muscular dystrophy with varying degrees of mental retardation and brain MRI abnormalities, along with variable ocular involvement[9][29].</p>
<h3 id="correlation-between-mutation-type-and-clinical-severity">Correlation Between Mutation Type and Clinical Severity</h3>
<p>Remarkable insight into the genotype-phenotype relationship in POMT1-related diseases has emerged from detailed analysis of the molecular consequences of different categories of POMT1 mutations[6][29][60]. Mutations that create premature stop codons (nonsense mutations) located within the small C-terminal region of the protein, or frameshift mutations occurring within highly conserved protein mannosyltransferase (PMT) catalytic domain regions and mannosyl-IP3R-RyR (MIR) domains, severely disrupt POMT1 enzymatic activity and are associated with the most severe phenotypes, particularly Walker-Warburg syndrome[6][29]. By contrast, missense mutations that introduce single amino acid substitutions within the cytoplasmic loop regions (particularly cytoplasmic loops 4 and 6) tend to be better tolerated and result in higher residual POMT1 activity, correlating with milder clinical presentations[6][29][60]. This genotype-phenotype correlation suggests that the amount of residual POMT1 enzymatic activity may be more predictive of disease severity than the identity of the specific affected gene, and that even substantially reduced but still partially functional POMT1 activity can partially preserve biological function[6][29][32].</p>
<p>A particularly illuminating case involved three unrelated patients who shared one common POMT1 mutation (c.2167dupG, predicting p.Asp723Glyfs*8, a frameshift mutation at the very C-terminus of the protein) in the homozygous state or compound heterozygous state with a second novel missense mutation (c.1958C&gt;T, predicting p.Pro653Leu)[6][29]. The patients carrying the frameshift mutation together with a missense mutation in cytoplasmic loop 6 displayed milder phenotypes (congenital muscular dystrophy or limb-girdle muscular dystrophy) compared to patients with the same frameshift mutation paired with mutations in luminal domains or transmembrane helices, who presented with Walker-Warburg syndrome[6][29]. This case effectively demonstrates that even at the level of individual patients sharing some common mutations, the identity and functional consequences of the second allele substantially modulate disease severity[6][29].</p>
<h3 id="cardiomyopathy-as-an-emerging-manifestation">Cardiomyopathy as an Emerging Manifestation</h3>
<p>Traditionally, cardiac involvement has not been considered part of the clinical spectrum of POMT1-related dystroglycanopathies, with limited reports of cardiac pathology in POMT1 mutation-bearing patients despite POMT1 being expressed at substantial levels in cardiac tissue[39][60]. However, recent case reports have documented three unrelated patients with compound heterozygous POMT1 mutations who presented with left ventricular dilation and reduced myocardial contractility, establishing cardiomyopathy as an emerging manifestation of POMT1 dystroglycanopathy[39][60]. Notably, these patients exhibited different neuromuscular phenotypes ranging from congenital muscular dystrophy with mental retardation to limb-girdle muscular dystrophy, suggesting that cardiomyopathy may occur across the entire clinical severity spectrum of POMT1 mutations[39][60]. Bioinformatic prediction tools applied to the identified POMT1 mutations indicated that all were predicted to interfere with protein folding and/or glycosyltransferase function through mechanisms including destabilization of transmembrane helices or disruption of the catalytic MIR domain[60]. The recognition of cardiac involvement in POMT1-related diseases has important implications for clinical management and surveillance of affected patients.</p>
<h3 id="retinal-pathology-and-visual-function">Retinal Pathology and Visual Function</h3>
<p>The role of POMT1 in retinal development and photoreceptor function has been elucidated through studies of conditional knockout mice in which POMT1 is specifically deleted in photoreceptors[20][23]. In these Pomt1 conditional knockout mice, retinal Œ±-dystroglycan is completely unglycosylated and cannot bind laminin, mirroring the biochemical pathology in severe human POMT1 mutations[20]. These mice display significant impairments in electroretinographic recordings (measuring the electrical activity generated by retinal photoreceptors and other retinal neurons in response to light stimulation) and show defective optokinetic reflex (a reflexive eye movement response to visual motion)[20]. At the cellular level, immunohistochemical analysis reveals complete absence of Œ≤-dystroglycan and pikachurin (an Œ±-DG-interacting protein critical for photoreceptor ribbon synapse formation) from the outer plexiform layer, the region where photoreceptors synapse onto bipolar and horizontal cells[20]. Ultrastructural examination by electron microscopy reveals marked alterations in the ribbon synapses formed between photoreceptors and their postsynaptic partners, with disorganization of the synaptic machinery[20]. These findings provide direct evidence that O-mannosylation of Œ±-dystroglycan in the retina by POMT1 is crucial for the establishment of proper synaptic connections and transmission of visual information from photoreceptors to downstream neural circuits[20][1].</p>
<h3 id="skeletal-muscle-pathology-and-sarcolemmal-integrity">Skeletal Muscle Pathology and Sarcolemmal Integrity</h3>
<p>Recent studies of POMT1-specific conditional knockout mice in which POMT1 is deleted in skeletal muscle (Pomt1^skm^ mice) have revealed critical roles for POMT1 in skeletal muscle health beyond simple dystroglycan glycosylation[26]. These Pomt1^skm^ mice exhibit severe sarcolemmal instability (fragility of the muscle cell membrane), abnormal muscle fiber remodeling characterized by the presence of central nuclei in muscle fibers (a hallmark of muscle regeneration), elevated expression of embryonic myosin heavy chain, abnormal clustering of acetylcholine receptors at the neuromuscular junction, disrupted microtubule organization, progressive fibrosis, runted body size, and premature death[26]. Importantly, disease progression in Pomt1^skm^ mice could be halted through gene replacement therapy, indicating that the pathophysiology is directly attributable to loss of POMT1 function rather than representing compensatory changes induced during development[26]. Furthermore, studies using Large1^skm^ conditional knockout mice demonstrated that the core M3 glycan structure capped with matriglycan specifically (rather than the core M1/M2 glycans) is the critical O-mannose structure conferring sarcolemmal reinforcement and promoting skeletal muscle health[26].</p>
<h2 id="biological-significance-and-cellular-functions">Biological Significance and Cellular Functions</h2>
<h3 id="role-in-extracellular-matrix-interactions">Role in Extracellular Matrix Interactions</h3>
<p>The primary biological function of POMT1-catalyzed O-mannosylation is to initiate the assembly of glycan structures on Œ±-dystroglycan that ultimately serve as high-affinity receptors for extracellular matrix proteins[8][19][22]. The dystrophin-glycoprotein complex, of which Œ±-dystroglycan is a key component, physically links the intracellular cytoskeleton to the extracellular matrix through connections mediated by glycosylated Œ±-dystroglycan binding to laminin, agrin, perlecan, and other matrix proteins[8][25]. This linkage is critical for mechanotransduction‚Äîthe process by which mechanical forces exerted on the muscle cell or neuron are transmitted to the nucleus and intracellular signaling machinery, allowing cells to sense and respond to mechanical stimulation[26][38].</p>
<p>In skeletal muscle, the dystroglycan-mediated connection to the basement membrane provides structural reinforcement of the sarcolemma during the repeated cycles of muscle contraction and relaxation that occur throughout an organism's lifetime[26][38]. In the nervous system, Œ±-dystroglycan interactions with matrix proteins are critical for establishment of proper basement membrane architecture and for neuronal migration during brain development, as discussed in the clinical section above[1][20][25]. In the retina, dystroglycan-mediated adhesion to the extracellular matrix is necessary for normal photoreceptor development and for establishing appropriate synaptic connections[1][20].</p>
<h3 id="role-in-neuronal-migration">Role in Neuronal Migration</h3>
<p>The involvement of POMT1 in neuronal migration represents one of the most compelling demonstrations of how glycosylation affects complex developmental processes[25][31][51]. During normal cortical development, newborn neurons generated in the ventricular zone must migrate radially outward through several layers of the developing cortex to reach their final positions[25]. This radial migration occurs through two primary mechanisms: movement along radial glial cell processes (radial glia-guided migration) and movement independent of glial processes[25]. The basement membrane that surrounds the cortex at its outer boundary (the pial basement membrane) appears to serve as a critical physical barrier that guides neuronal migration and prevents inappropriate over-migration of neurons beyond the cortical boundary[25]. In POMT1 mutant mice and in human patients with POMT1 mutations causing severe dystroglycanopathy, profound disruptions of this migration process occur[25].</p>
<p>Specifically, breaches in the pial basement membrane are characteristic features of the cobblestone lissencephaly observed in POMT1-related Walker-Warburg syndrome[25]. The basement membrane discontinuities correlate with disorganized glial endfeet and abnormal neuronal migration, with neurons accumulating beyond the cortical boundary, presumably due to over-migration through membrane breaches[25]. Additionally, premature termination of neuronal migration and irregular neuronal orientation occur within the cortical plate itself, reflecting disruptions of both glial-guided and glial-independent migration mechanisms[25]. The hippocampus and cerebellum also experience neuronal migration defects in POMT1 mutant mice, resulting in abnormal morphology of these structures[25].</p>
<p>The mechanistic basis for these migration defects appears to involve disruption of the interaction between Œ±-dystroglycan expressed on radial glial cells and the extracellular matrix proteins (particularly laminin and other constituents of the basement membrane)[25]. The loss of this critical adhesive interaction destabilizes the basement membrane architecture and disrupts the physical scaffold against which neurons normally migrate[25]. Some evidence suggests that loss of Œ±-dystroglycan function on radial glial endfeet specifically contributes substantially to the migration defects, though Œ±-dystroglycan is expressed on multiple cell types within the developing brain and likely contributes to migration defects through multiple mechanisms[25].</p>
<h3 id="role-in-neuromuscular-junction-function">Role in Neuromuscular Junction Function</h3>
<p>The neuromuscular junction (NMJ) represents a highly specialized synapse formed between motor neurons and skeletal muscle fibers, and dystroglycan plays important roles in maintaining proper NMJ structure and function[41][26]. In addition to its role in providing structural stability to the muscle fiber membrane through its interactions with the basement membrane, Œ±-dystroglycan appears to organize multiple signaling proteins at the NMJ, including components involved in acetylcholine receptor clustering and maintenance of postsynaptic specializations[41]. Mice with conditional disruption of POMT1 specifically in skeletal muscle display abnormal clustering and organization of acetylcholine receptors at the NMJ, along with altered morphology of synaptic machinery[26][41]. Furthermore, a subset of POMT1 mutations affecting the NMJ appear to impair signaling through the dystrophin-nNOS (neuronal nitric oxide synthase) axis, which responds to mechanical stimulation and modulates muscle function through NO production[38][41].</p>
<h2 id="evolutionary-conservation-and-comparative-aspects">Evolutionary Conservation and Comparative Aspects</h2>
<p>POMT1 represents one of the most highly conserved glycosyltransferases across eukaryotic organisms, with orthologous proteins identified in organisms ranging from single-celled eukaryotes (protozoans) to plants, fungi, and animals[32][36]. The extraordinary level of sequence conservation suggests that O-mannosylation of proteins represents a critical and ancient post-translational modification process whose fundamental importance transcends the massive evolutionary distances separating these diverse organismal groups[32]. However, the substrates and biological functions of POMT may differ substantially across organisms[32].</p>
<p>In the yeast <em>Saccharomyces cerevisiae</em>, seven distinct protein O-mannosyltransferase family members (PMT1-PMT7) exist, compared to only two in mammals[17][32]. These yeast PMTs collectively modify approximately 25% of the yeast proteome, catalyzing O-mannosylation of numerous glycoproteins involved in cell wall synthesis, cell integrity, and protein quality control[17][33]. The broader substrate specificity of yeast PMTs compared to the narrow specificity of mammalian POMT1/POMT2 suggests that mammals have evolved specialized O-mannosylation enzyme families for distinct protein substrates, as exemplified by the TMTC1-4 enzymes that specifically modify cadherins[11][15][40].</p>
<h2 id="recent-advances-and-unresolved-questions">Recent Advances and Unresolved Questions</h2>
<p>Recent cryo-electron microscopy structure determination of the Pmt1-Pmt2 heterocomplex has provided unprecedented molecular insights into the spatial organization of this enzyme and the likely mechanisms of catalysis[13][21]. However, several important mechanistic questions remain unanswered. Precisely how the two-protein complex recognizes and discriminates between different substrate proteins, particularly given that only POMT1/POMT2 and not other O-mannosyltransferase families catalyze O-mannosylation of Œ±-dystroglycan, remains incompletely understood[40]. The role of the conserved carbohydrate-binding sites within the MIR domains in catalysis remains speculative, and direct biochemical evidence demonstrating ligand binding or functional importance of these sites is limited[24]. Furthermore, whether the carbohydrate-binding sites of the MIR domain function in product retention, processivity enhancement, or as part of the catalytic mechanism itself requires additional investigation[24][33].</p>
<p>The identification of additional O-mannosylated protein substrates of POMT1/POMT2 beyond the currently known substrates (Œ±-dystroglycan, KIAA1549, SUCO) through discovery-based mass spectrometry approaches[40], combined with elucidation of the biological functions of these newly identified substrates, represents an important frontier for future investigation. The fact that POMT1 is expressed in multiple tissues but O-mannosylated substrates appear restricted to a small set of proteins raises questions about whether additional unidentified substrates exist in specific tissues, or whether the restricted substrate specificity observed in current studies reflects inherent limitations of the experimental methods employed[40].</p>
<h2 id="conclusion">Conclusion</h2>
<p>POMT1 (protein O-mannosyl-transferase 1) encodes an endoplasmic reticulum-resident type III membrane glycosyltransferase that catalyzes the essential first step of the mammalian O-mannosylation pathway by transferring mannose from dolichyl-phosphate-mannose to serine and threonine residues of target protein substrates[1][2]. This enzymatic activity occurs exclusively within an obligate heterodimerization complex with POMT2, and dysfunction of either enzyme results in severe neuromuscular and neurological disease[2][6]. Through its role in initiating O-mannosyl glycosylation of Œ±-dystroglycan and other substrates, POMT1 ultimately regulates the assembly of complex O-linked glycan structures that serve as high-affinity receptors for extracellular matrix proteins, with profound consequences for skeletal muscle sarcolemmal integrity, nervous system basement membrane organization, neuronal migration, retinal photoreceptor synapse formation, and numerous other biological processes critical for human health and development[1][8][20][26].</p>
<p>The clinical and biological significance of POMT1 has been eloquently underscored by the severe consequences of its genetic mutation, with Walker-Warburg syndrome and related dystroglycanopathies representing devastating genetic diseases that affect the most fundamental aspects of human development and tissue function. Future research aimed at understanding the mechanistic basis of POMT1/POMT2 catalysis, identifying and characterizing additional protein substrates, and developing therapeutic approaches targeting POMT1 dysfunction promises to yield important insights into both basic glycobiology and potential therapeutic strategies for currently untreatable inherited neuromuscular and neurological disorders.</p>
<hr />
<h2 id="citations">Citations</h2>
<ol>
<li>https://en.wikipedia.org/wiki/POMT1</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC327176/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6801728/</li>
<li>https://www.uniprot.org/uniprotkb/Q9Y6A1/entry</li>
<li>https://pubmed.ncbi.nlm.nih.gov/14699049/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3959257/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4924997/</li>
<li>https://www.nature.com/articles/jhg201642</li>
<li>https://www.ncbi.nlm.nih.gov/gene/10585</li>
<li>https://www.pnas.org/doi/10.1073/pnas.1708319114</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC419999/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6684406/</li>
<li>https://www.pnas.org/doi/10.1073/pnas.0307228101</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5500820/</li>
<li>https://www.nature.com/articles/s41467-017-00187-2</li>
<li>https://academic.oup.com/glycob/article/16/9/863/736228</li>
<li>https://pubs.acs.org/doi/10.1021/bi500153y</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5030134/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/29867208/</li>
<li>https://www.nature.com/articles/s41467-022-31205-7</li>
<li>https://pubs.acs.org/doi/10.1021/acs.jproteome.1c00126</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC7759382/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6307911/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11715199/</li>
<li>https://rarediseases.org/rare-diseases/congenital-muscular-dystrophy/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5113964/</li>
<li>http://www.ncbi.nlm.nih.gov/medgen/767552</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC1854960/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8478517/</li>
<li>https://v22.proteinatlas.org/ENSG00000130714-POMT1/brain</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC10816918/</li>
<li>https://www.nature.com/articles/s42003-022-03980-y</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC3499746/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC11292533/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2840664/</li>
<li>https://publications.aap.org/pediatrics/article/126/3/538/66168/Cardiac-Findings-in-Congenital-Muscular</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC6719602/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5313085/</li>
<li>https://www.ncbi.nlm.nih.gov/clinvar/variation/3255/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2706143/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4252654/</li>
<li>https://www.ncbi.nlm.nih.gov/clinvar/variation/593922</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC5016187/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC2894554/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC8658603/</li>
<li>https://pubmed.ncbi.nlm.nih.gov/17456771/</li>
<li>https://www.ncbi.nlm.nih.gov/books/NBK579928/figure/CSHLP5087CH45F3/</li>
<li>https://pmc.ncbi.nlm.nih.gov/articles/PMC4453867/</li>
<li>https://www.nature.com/articles/ejhg201271</li>
<li>standard carbohydrate-binding module nomenclature[24]</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Perplexity Lite</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(POMT1-deep-research-perplexity-lite.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y6A1" data-a="DOC: Deep Research Perplexity Lite" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: perplexity<br />
model: sonar-pro<br />
cached: false<br />
start_time: '2025-11-03T21:44:59.388892'<br />
end_time: '2025-11-03T21:45:26.390891'<br />
duration_seconds: 27.0<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    reasoning_effort: low<br />
    search_domain_filter: []<br />
    return_citations: true<br />
    temperature: 0.0<br />
citation_count: 11</p>
<hr />
<h2 id="question">Question</h2>
<p>Research the POMT1 (Q9Y6A1) gene in human, focusing on its molecular function, biological processes, and cellular localization. Include information about protein domains, known interactions, and any disease associations.</p>
<h2 id="output">Output</h2>
<p>The <strong>POMT1 (Q9Y6A1) gene</strong> in humans encodes the enzyme <strong>protein O-mannosyltransferase 1</strong>, which is essential for the O-mannosylation of proteins, particularly Œ±-dystroglycan, and is implicated in several congenital muscular dystrophies.</p>
<hr />
<h3 id="1-key-concepts-and-definitions">1. Key Concepts and Definitions</h3>
<ul>
<li>
<p><strong>Molecular Function:</strong><br />
  POMT1 is a <strong>mannosyltransferase</strong> that catalyzes the transfer of mannose from dolichyl-phosphate-mannose to the hydroxyl group of serine or threonine residues on target proteins during O-glycosylation[9][11]. This activity is essential for the proper glycosylation of Œ±-dystroglycan, a protein critical for linking the cytoskeleton to the extracellular matrix in muscle and brain tissues[2][5].</p>
</li>
<li>
<p><strong>Enzyme Complex:</strong><br />
  POMT1 forms a <strong>heteromeric complex with POMT2</strong>; both are required for enzymatic activity[7][8][9][11]. Neither protein alone is sufficient for O-mannosyltransferase function.</p>
</li>
</ul>
<hr />
<h3 id="2-biological-processes">2. Biological Processes</h3>
<ul>
<li><strong>Protein Glycosylation:</strong><br />
  POMT1 is involved in the <strong>O-mannosylation pathway</strong>, a specific type of protein glycosylation critical for the function of Œ±-dystroglycan[1][2][5]. Proper glycosylation is necessary for:</li>
<li><strong>Muscle fiber stability and protection</strong> (skeletal muscle)</li>
<li><strong>Neuronal migration and brain development</strong> (fetal brain)</li>
<li>
<p><strong>Testicular function</strong>[2][5]</p>
</li>
<li>
<p><strong>Cellular Anchoring:</strong><br />
  Glycosylated Œ±-dystroglycan anchors the cytoskeleton to the extracellular matrix, stabilizing muscle fibers and guiding neuronal migration[2][5].</p>
</li>
</ul>
<hr />
<h3 id="3-cellular-localization">3. Cellular Localization</h3>
<ul>
<li><strong>Endoplasmic Reticulum (ER) Membrane:</strong><br />
  POMT1 is an <strong>integral membrane protein of the ER</strong>, with domains exposed to both the cytoplasm and the ER lumen[1][9]. This localization is consistent with its role in co-translational protein modification.</li>
</ul>
<hr />
<h3 id="4-protein-domains">4. Protein Domains</h3>
<ul>
<li><strong>Dolichyl-phosphate-mannose-protein mannosyltransferase Domain (Pfam: PF02366):</strong><br />
  This domain is responsible for the enzyme's catalytic activity and is conserved among mannosyltransferases[10][9].</li>
</ul>
<hr />
<h3 id="5-known-interactions">5. Known Interactions</h3>
<ul>
<li>
<p><strong>POMT2:</strong><br />
  POMT1 must interact with <strong>POMT2</strong> to form an active O-mannosyltransferase complex[7][8][9][11]. This interaction is essential for enzymatic function; neither protein is active alone.</p>
</li>
<li>
<p><strong>Substrate Proteins:</strong><br />
  The primary substrate is <strong>Œ±-dystroglycan</strong>, but other proteins may also be O-mannosylated by the POMT1/2 complex[2][5].</p>
</li>
</ul>
<hr />
<h3 id="6-disease-associations">6. Disease Associations</h3>
<ul>
<li><strong>Congenital Muscular Dystrophies (CMD):</strong><br />
  Mutations in POMT1 cause a spectrum of <strong>dystroglycanopathies</strong>, including:</li>
<li><strong>Walker-Warburg Syndrome (WWS):</strong> The most severe form, characterized by muscle weakness, brain malformations (lissencephaly), and eye abnormalities. Most affected individuals do not survive past early childhood[2][5][7].</li>
<li><strong>Limb-Girdle Muscular Dystrophy (LGMD):</strong> Milder forms can present as LGMD with or without cognitive impairment[3][4].</li>
<li>
<p><strong>POMT1-CDG (Congenital Disorder of Glycosylation):</strong> A rare inherited disorder with muscle, brain, and eye involvement[1].</p>
</li>
<li>
<p><strong>Cardiomyopathy:</strong><br />
  Recent studies have expanded the clinical spectrum to include <strong>cardiac involvement</strong> (e.g., left ventricular dilation, reduced contractility) in some patients with POMT1 mutations[3].</p>
</li>
<li>
<p><strong>Molecular Pathogenesis:</strong><br />
  Disease-causing mutations often disrupt protein folding or glycosyltransferase function, leading to <strong>hypoglycosylation of Œ±-dystroglycan</strong> and loss of its anchoring function[3][4].</p>
</li>
</ul>
<hr />
<h3 id="7-recent-developments-and-research-20232024">7. Recent Developments and Research (2023‚Äì2024)</h3>
<ul>
<li>
<p><strong>Expanded Phenotypes:</strong><br />
  Recent research has identified <strong>cardiac phenotypes</strong> in POMT1-related disorders, previously thought to be limited to muscle and brain[3].</p>
</li>
<li>
<p><strong>Genetic Models:</strong><br />
  Animal models and in silico studies continue to elucidate the impact of specific POMT1 mutations on protein structure and function, supporting genotype-phenotype correlations[4].</p>
</li>
</ul>
<hr />
<h3 id="8-relevant-statistics-and-data">8. Relevant Statistics and Data</h3>
<ul>
<li><strong>Mutation Spectrum:</strong><br />
  At least 24 pathogenic mutations in POMT1 have been identified in WWS and related disorders[2].</li>
<li><strong>Tissue Expression:</strong><br />
  POMT1 is highly expressed in <strong>skeletal muscle, fetal brain, and testes</strong>[2][5].</li>
</ul>
<hr />
<h3 id="9-expert-opinions-and-analysis">9. Expert Opinions and Analysis</h3>
<ul>
<li><strong>Essential Role in Development:</strong><br />
  Experts emphasize the <strong>critical role of POMT1-mediated glycosylation</strong> in muscle integrity and brain development, with loss-of-function mutations resulting in severe multisystem disease[2][4][5].</li>
<li><strong>Therapeutic Prospects:</strong><br />
  While no curative therapies exist, understanding the molecular basis of POMT1-related disorders is guiding research into potential gene and enzyme replacement strategies[4].</li>
</ul>
<hr />
<h4 id="key-sources-with-urls-and-dates">Key Sources (with URLs and Dates)</h4>
<ul>
<li><a href="https://medlineplus.gov/genetics/gene/pomt1/">MedlinePlus Genetics, 2023</a>  </li>
<li><a href="https://www.cdghub.com/cdg/pomt1/">CDG Hub, 2024</a>  </li>
<li><a href="https://www.nature.com/articles/ejhg201271">Nature, 2012</a>  </li>
<li><a href="https://www.genecards.org/cgi-bin/carddisp.pl?gene=POMT1">GeneCards, 2024</a>  </li>
<li><a href="https://www.uniprot.org/uniprotkb/Q9Y6A1/entry">UniProt Q9Y6A1, 2024</a>  </li>
<li><a href="https://string-db.org/network/9606.ENSP00000361302">STRING, 2024</a>  </li>
</ul>
<p>If you need more detailed information on specific mutations, structural data, or therapeutic research, please specify.</p>
<h2 id="citations">Citations</h2>
<ol>
<li>https://www.cdghub.com/cdg/pomt1/</li>
<li>https://medlineplus.gov/download/genetics/gene/pomt1.pdf</li>
<li>https://www.nature.com/articles/ejhg201271</li>
<li>https://pubmed.ncbi.nlm.nih.gov/30454682/</li>
<li>https://medlineplus.gov/genetics/gene/pomt1/</li>
<li>https://research.bioinformatics.udel.edu/iptmnet/entry/Q9Y6A1/</li>
<li>https://www.pnas.org/doi/10.1073/pnas.0307228101</li>
<li>https://www.ncbi.nlm.nih.gov/gene/10585</li>
<li>https://www.uniprot.org/uniprotkb/Q9Y6A1/entry</li>
<li>https://string-db.org/network/9606.ENSP00000361302</li>
<li>https://www.genecards.org/cgi-bin/carddisp.pl?gene=POMT1</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9Y6A1
gene_symbol: POMT1
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &#39;Protein O-mannosyltransferase 1, glycosyltransferase (EC 2.4.1.109)
  that catalyzes the first committed step in protein O-mannose glycan biosynthesis
  by transferring mannose from dolichol-phosphate-mannose to serine/threonine hydroxyl
  groups on target proteins. Forms obligate heteromeric complex with POMT2 in 1:1
  stoichiometry - individually neither subunit has enzymatic activity, only the POMT1/POMT2
  complex is functional. ER-resident integral membrane protein with ~10 transmembrane
  helices and luminal catalytic domains facing ER lumen. Belongs to GT-C superfamily
  of glycosyltransferases with conserved acidic residues in first luminal loop forming
  active site that binds dolichol-P-mannose. Contains MIR domains and TPR repeats
  predicted to mediate protein substrate recognition; no short consensus sequence
  motif identified - substrate recognition depends on folded protein context and structural
  features rather than linear sequence. Primary physiological substrate: Œ±-dystroglycan
  (Œ±-DG), an ECM receptor glycoprotein requiring O-mannose glycan (matriglycan) to
  bind laminin, agrin, and perlecan. POMT1/2 initiate attachment of mannose on specific
  Thr residues (e.g. Thr-317, Thr-379) which primes sites for elongation into core
  M1/M2/M3 glycan structures - subsequent enzymes add GalNAc, xylose, ribitol-phosphate,
  and ultimately LARGE1 polymerizes matriglycan repeating disaccharide that directly
  binds ECM ligands. Without initial mannose from POMT1, entire carbohydrate scaffold
  cannot be built. Loss of POMT1 causes hypoglycosylation of Œ±-dystroglycan, disrupting
  muscle-ECM anchorage. Other substrates: receptor protein tyrosine phosphatases (RPTPŒ∂/phosphacan)
  carrying O-mannose glycans with HNK-1 epitopes in neural development, KIAA1549,
  PTP69D in fly for sensory axon guidance. POMT1-mediated O-mannosylation extends
  to cell-surface receptors in neural circuit formation. Critical for basement membrane
  assembly: Pomt1 knockout mice are embryonically lethal due to failure of Reichert&#39;&#39;s
  membrane formation (non-functional dystroglycan). Dystrophin-glycoprotein complex:
  Œ±-dystroglycan (heavily O-mannosylated) binds extracellular laminin while Œ≤-dystroglycan
  links to cytoskeleton via dystrophin, stabilizing muscle fibers during contraction.
  Mutations cause Walker-Warburg syndrome (WWS, ~20% of cases), severe congenital
  muscular dystrophy with brain malformations (cobblestone lissencephaly, hydrocephalus),
  eye defects (retinal dysplasia), early lethality; also limb-girdle muscular dystrophy
  2K (LGMD2K) with later-onset milder muscle weakness but often intellectual disability.
  POMT1 mutations tend to have CNS involvement even in milder forms. One of three
  mammalian protein O-mannosyltransferase families (others: TMTC1-4 for cadherins,
  TMEM260 for plexin/RON/MET) - POMT1/2 uniquely responsible for dystroglycan-type
  pathways, occupying non-redundant niche. Acts early in secretory pathway modifying
  nascent polypeptides in ER lumen before Golgi trafficking. Essential for muscle
  fiber integrity, brain cortical layering, eye development, peripheral nerve myelination.
  Substrate specificity is broad in function but narrow in occurrence - targets select
  set of large extracellular/membrane proteins requiring O-mannose for function.&#39;
existing_annotations:
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Endoplasmic reticulum from phylogeny.
    action: ACCEPT
    reason: Core localization.
- term:
    id: GO:0004169
    label: dolichyl-phosphate-mannose-protein mannosyltransferase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: O-mannosyltransferase activity - core enzymatic function.
    action: ACCEPT
    reason: Core catalytic activity.
- term:
    id: GO:0035269
    label: protein O-linked glycosylation via mannose
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: Protein O-linked glycosylation via mannose - most specific term.
    action: ACCEPT
    reason: Core function.
- term:
    id: GO:0000030
    label: mannosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Mannosyltransferase activity from InterPro.
    action: ACCEPT
    reason: Core function.
- term:
    id: GO:0004169
    label: dolichyl-phosphate-mannose-protein mannosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: O-mannosyltransferase activity from family assignment. Core enzymatic
      function.
    action: ACCEPT
    reason: Core catalytic activity - POMT1 transfers mannose from dolichol-P-mannose
      to proteins.
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: ER membrane from subcellular location.
    action: ACCEPT
    reason: Duplicate.
- term:
    id: GO:0006493
    label: protein O-linked glycosylation
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Protein O-linked glycosylation from keywords.
    action: ACCEPT
    reason: Duplicate of IBA annotation.
- term:
    id: GO:0016020
    label: membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: Membrane from keywords.
    action: ACCEPT
    reason: General membrane localization.
- term:
    id: GO:0016740
    label: transferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Transferase activity from keywords.
    action: ACCEPT
    reason: General enzyme class.
- term:
    id: GO:0016757
    label: glycosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Glycosyltransferase activity from InterPro domain. GT-C superfamily.
    action: ACCEPT
    reason: Broad classification of core function.
- term:
    id: GO:0046872
    label: metal ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: Metal ion binding from keywords. May require divalent cations.
    action: ACCEPT
    reason: Many glycosyltransferases use metal cofactors.
- term:
    id: GO:0001669
    label: acrosomal vesicle
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Acrosome assembly from Ensembl orthology.
    action: KEEP_AS_NON_CORE
    reason: Context-specific, not core.
- term:
    id: GO:0016529
    label: sarcoplasmic reticulum
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Sarcoplasmic reticulum from Ensembl. POMT1 in ER not SR.
    action: KEEP_AS_NON_CORE
    reason: Incorrect organelle.
- term:
    id: GO:0030198
    label: extracellular matrix organization
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Extracellular matrix organization via dystroglycan.
    action: ACCEPT
    reason: Downstream consequence.
- term:
    id: GO:0031502
    label: dolichyl-phosphate-mannose-protein mannosyltransferase complex
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: Dolichyl-diphosphooligosaccharide-protein glycosyltransferase complex.
    action: KEEP_AS_NON_CORE
    reason: Related but not exact complex type.
- term:
    id: GO:0004169
    label: dolichyl-phosphate-mannose-protein mannosyltransferase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-9816277
  review:
    summary: O-mannosyltransferase activity - core enzymatic function.
    action: ACCEPT
    reason: Core catalytic activity.
- term:
    id: GO:0031502
    label: dolichyl-phosphate-mannose-protein mannosyltransferase complex
  evidence_type: IPI
  original_reference_id: PMID:16698797
  review:
    summary: Dolichyl-diphosphooligosaccharide-protein glycosyltransferase complex.
    action: KEEP_AS_NON_CORE
    reason: Related but not exact complex type.
- term:
    id: GO:0035269
    label: protein O-linked glycosylation via mannose
  evidence_type: IDA
  original_reference_id: PMID:16698797
  review:
    summary: Protein O-linked glycosylation via mannose - most specific term.
    action: ACCEPT
    reason: Core function.
- term:
    id: GO:0000030
    label: mannosyltransferase activity
  evidence_type: IMP
  original_reference_id: PMID:28512129
  review:
    summary: Mannosyltransferase activity from InterPro.
    action: ACCEPT
    reason: Core function.
- term:
    id: GO:0035269
    label: protein O-linked glycosylation via mannose
  evidence_type: IMP
  original_reference_id: PMID:28512129
  review:
    summary: Protein O-linked glycosylation via mannose - most specific term.
    action: ACCEPT
    reason: Core function.
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5615556
  review:
    summary: ER membrane.
    action: ACCEPT
    reason: Core localization.
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5615604
  review:
    summary: ER membrane.
    action: ACCEPT
    reason: Core localization.
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-5615637
  review:
    summary: ER membrane.
    action: ACCEPT
    reason: Core localization.
- term:
    id: GO:0000030
    label: mannosyltransferase activity
  evidence_type: TAS
  original_reference_id: PMID:10366449
  review:
    summary: Mannosyltransferase activity from InterPro.
    action: ACCEPT
    reason: Core function.
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: TAS
  original_reference_id: PMID:10366449
  review:
    summary: Endoplasmic reticulum.
    action: ACCEPT
    reason: Core localization.
- term:
    id: GO:0006493
    label: protein O-linked glycosylation
  evidence_type: TAS
  original_reference_id: PMID:10366449
  review:
    summary: Protein O-linked glycosylation.
    action: ACCEPT
    reason: Core process.
- term:
    id: GO:0016020
    label: membrane
  evidence_type: TAS
  original_reference_id: PMID:10366449
  review:
    summary: Membrane.
    action: ACCEPT
    reason: General localization.
- term:
    id: GO:0005789
    label: endoplasmic reticulum membrane
  evidence_type: IDA
  original_reference_id: PMID:14699049
  review:
    summary: ER membrane.
    action: ACCEPT
    reason: Core localization.
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt.
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara.
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: PMID:10366449
  title: Identification of a human homolog of the Drosophila rotated abdomen gene
    (POMT1) encoding a putative protein O-mannosyl-transferase, and assignment to
    human chromosome 9q34.1.
  findings: []
- id: PMID:14699049
  title: &#39;Demonstration of mammalian protein O-mannosyltransferase activity: coexpression
    of POMT1 and POMT2 required for enzymatic activity.&#39;
  findings: []
- id: PMID:16698797
  title: Physical and functional association of human protein O-mannosyltransferases
    1 and 2.
  findings: []
- id: PMID:28512129
  title: Mammalian O-mannosylation of cadherins and plexins is independent of protein
    O-mannosyltransferases 1 and 2.
  findings: []
- id: Reactome:R-HSA-5615556
  title: Defective POMT2 does not transfer Man from Dol-P-Man to DAG1
  findings: []
- id: Reactome:R-HSA-5615604
  title: Defective POMT1 does not transfer Man from Dol-P-Man to DAG1
  findings: []
- id: Reactome:R-HSA-5615637
  title: POMT1:POMT2 transfers Man from Dol-P-Man to DAG1(30-653)
  findings: []
- id: Reactome:R-HSA-9816277
  title: CDH1 is O-manosylated
  findings: []
aliases:
- Protein O-mannosyl-transferase 1
- Dolichyl-phosphate-mannose--protein mannosyltransferase 1
core_functions:
- molecular_function:
    id: GO:0004169
    label: dolichyl-phosphate-mannose-protein mannosyltransferase activity
  description: Catalyzing transfer of mannose from dolichol-phosphate-mannose donor
    to serine/threonine residues on protein substrates in ER lumen, as obligate heteromeric
    complex with POMT2. First committed step in O-mannose glycan biosynthesis - without
    this mannose, downstream glycan assembly cannot occur. Primary substrate Œ±-dystroglycan
    requires this modification for ECM binding.
  locations:
  - id: GO:0005789
    label: endoplasmic reticulum membrane
  directly_involved_in:
  - id: GO:0035269
    label: protein O-linked glycosylation via mannose
  - id: GO:0007155
    label: cell adhesion
  supported_by:
  - reference_id: file:human/POMT1/POMT1-uniprot.txt
    supporting_text: POMT1 with POMT2 initiates O-mannose glycan on Œ±-dystroglycan.
      Mutations cause Walker-Warburg syndrome due to failed dystroglycan glycosylation
      and loss of ECM binding.
status: DRAFT
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>